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INTRODUCTION 
Herbal Medicine
10-11, 39
  
Herbal and products containing herb(s) have been in trade and commerce and are 
currently used for variety of purpose. 
 The WHO defined an herb as being fresh (or) dried, fragmented (or) powdered plant 
material, it can be used in this order state (or) further processed and formulated to become the 
final herbal product. Treatment of herbs by squeezing, steaming, roasting, detecting (or) 
infusing in water. 
Extracting with alcohol (or) sweetening and baking with honey can create herbal 
products such as juices, tinctures, decoctions, infusions, gums, fixed oil, essential oil and 
resins. These may be used medically (or) as the starting material for additional processing 
and as food ingredients.  
Herbal medicines are plant derived materials and preparations with therapeutic (or) 
other human health benefits. Which contain either raw (or) processed ingredient from one 
(or) more plants, inorganic materials or animal origin. Herbal medicine preparations are 
developed are created drugs by the modern pharmaceutical industry. 
 Now a day, they are manufactured and sold most widely on the pharmaceutical 
market for curing diseases and promoting public health in India. 
Of the 2,50,000 higher plant species on earth, more than 80,000 are medicine. India is 
one of the world‟s 12 biodiversity centres with the presence of over 45,000 different plant 
species. 
Herbal formulation
5
  
      The herbal formulation consists of a selective combination of individual herbal 
ingredients that are formulated for a specific ailment or group of diseases conditions. When 
herbs combine together, they become more potent and effective within the body than 
individual herb due to their activating or catalyzing influence over one another. Herbal 
medicines are prepared from plant materials which are prone to contamination, deterioration 
and variation in composition. Therefore, quality control of herbal medicine offers a host of 
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problems. To solve this problem, first and foremost task is the selection of the right kind of 
plant material which is therapeutically efficacious. 
Advantages of Herbal Medicines 
They have large amount of use  
They have better patient tolerance as well as acceptance  
The medicinal plants have renewable source of cheaper medicines. 
Improvements in the quality, efficacy and safety of herbal medicines with the 
development of science and technology. 
Prolong and apparently uneventful use of herbal medicines may offer testimony of 
their safety and efficacy. 
They are cheap in cost. 
They are not harmful. 
They are more effective than any synthetic drug. 
Throughout the world herbal medicines have provided many of the most potent 
medicines to the vast arsenal of drugs available to modern medical science, both in crude 
form. 
In India, drugs of herbal origin have been used in traditional systems of medicines 
such as Unani, Ayurveda and Siddha. 
AYURVEDA-A LIFE SCIENCE
1
 
Ayurveda, which literally means the science of life (Ayur=life, Veda=science), 
Ayurveda is an ancient medical science which has developed in India thousands of years ago. 
It believed to have been passed on humans from the God themselves. Ayurveda developed 
and evolved into what it is today from several ancient treaties, most notably Adharva Veda 
which dates back to 5000 years. The ancient Vedic literature by sages has clearly laid out 
instruction to maintain health as well as fighting illness through therapies, massages, herbal 
medicines, diet control and exercises. 
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SHORT HISTORY OF AYURVEDA
2
 
Ayurveda system of medicine uses 700 species, Unani 700,Siddha 600,and modern 
medicine around 30 species. Ayurveda is a medical syatem primarily praticed in India that 
has been known for nearly 5000 years. It includes diet and herbal remedies, while 
emphasizing the body, mind and sprit in diseases prevention and treatment. 
WHO has also issued Guidelines defined the basic criteria for the evaluation of 
quality, safety and efficacy of herbal medicines with the goal of assisting national regulatory 
authorities, scientific organizations and manufacturers in assessing documentation, 
submissions and dossiers in respect of such products. Ayurveda is an unequivocally holistic 
tradition that reaches far beyond the realms of physical health, healing and the prevention of 
disease. It has a remarkable capacity to help each of us sync up with our truest inner nature, 
honour and develop our strengths, hone in on our challenge areas, redirect detrimental 
tendencies, and offer real support wherever it is needed-so that we can better maintain 
balance in the face of adversity. Ayurveda is a way of life that can help each of us to claim 
and celebrate our capacity for a fully embodied sense of wellness. 
DISEASE PROFILE
4
 
Skin disease are most common form of infections occurring in people of all ages skin 
disorders due to its ugliness and accustomed to especially when it is located in a place that is 
difficult to conceal like the face, even with makeup. Most of the skin infections treatment 
take long time to show their effects. The problem becomes more worrisome if the ailment 
does not respond  to skin disorder treatments. There are not many statistics to prove the exact 
frequency of skin diseases in this country, but general impression is 10-20 present of patients 
seeking medical advice suffer from skin diseases. The skin conditions are prevailant across 
all parts of the world. Sun is one of the most prominent source of skin cancer and related 
traumas. Besides this, they are a great handicap in the society, because they are visible. 
Fortunately, cutaneous scars can be successfully removed by plastic planning, laser therapy 
and skin grafting. 
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SIGN AND SYMPTOMS OF DISEASES 
What is a symptom? 
Symptom; Any subjective evidence of disease. A symptom is a phenomenon that is 
experienced by an individual. Anxiety, lower back pain, and fatigue are all symptoms. They 
are sensatious only the patient can perceive. In contrast, a sign is objective eveidence of 
disease.A bloody nose is a sign. It is evident to the patient, doctor, nurse, and other observers. 
What is a sign? 
Sign: Any objective evidence of disease. A sign can be detected by a person other 
than the affected individual. Gross blood in the stool is a sign of disease. It can be recognized 
by the patient, doctor, nurse, or others. Incontrast, a symptom is, by its nature, subjective. 
Abdominal pain is a symptom. It is something only the patient can know. 
THERE ARE MAIN TYPES OF SKIN DISEASE 
Skin infections, 
Bacterial infection 
Skin tumors 
Skin care 
Fungal skin infection 
Caring for the skin 
Virus infection and many more. 
        In recent years, attention has been directed towards the numerous ways in which 
immune cells of the skin interact with keratinocytes (kcs) to drive a multitude of skin 
diseases. Both recent immune cells and skin infiltrating cells can work synergistically with 
kcs to propagate disease pathogenesis. Activated kcs produce chemokines that recruit 
immune cells into the skin, which than initiate cascades of cellular and molecular events that 
are clearly responsible for the chronic nature of many inflammatory skin diseases. The 
concept that many skin diseases have a critical immune system component, or are auto-
immune in nature, is now well accepted. 
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THE FOLLOWING DIFFERENT TYPES OF SKIN DISEASES AND 
PICTURES 
ABSCESS ACANTHOSIS NIGRICANS 
  
An abscess is an infection characterized by a 
collection of pus underneath a portion on the 
skin. Most abscess are caused by a bacterial 
infection. 
Acanthosis nigricans is a condition 
characterised by abnormal thickening and 
darkening of the skin. Some of the main 
causes of acanthosis nigricans are obesity, 
syndroms and hormone problems, 
Medication, Genes, and Cancer. 
 
ACNE ACNE EXCORIEE 
  
 
Acne is characterised by comedones 
(blackheads and whiteheads) and pus-filled 
spots (pustules).This causes the glands to 
produce an excess of oil. 
 
Acne excoriee, also known as “picker‟s 
acne,” results when acne lesions are 
compulsively squeezed and scratched, 
resulting in scabs and scars. Caused by 
propionibacterium acnes and medications 
such as lithium, cortisone, hormones, iodides, 
some seizure medications, or isoniazid can 
also cause acne lessions. 
WARTS TINEA CORPORIS 
  
Warts are raised bumbs on your skin caused 
by the human papillomavirus (HPV) 
Ringworm of the body is a skin infection, 
caused by a fungus. A group of fungi 
dermatophytes cause ringworm. 
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ACTINIC KERATOSIS ALLERGIC CONTACT DERMATITIS 
  
 
Actinic keratoses, also known as solar 
keratoses, are small rough or scaly areas of 
skin due to damage from sun exposure. 
 
Allergic contact dermatitis is an allergyto a 
substance (the allergen) touching the skin. 
The reaction occurs 48-72 hours after 
exposure. Commen allergents are nickel, 
chromates, rubber chemicals, and 
antibacterial medication. 
ALOPECIA AREATA ANTHRAX 
  
 
Alopecia areata is a specific, common cause 
of hair loss that can occur at any age. The   
Alopecia areata is caused by autoimmunity, 
such as thyroid diseases, diabetes, stress and 
vitamin deficiencies. 
 
Anthrax is a disease caused by the bacterium 
Bacillus anthracis, a bacterium that has the 
ability to form spores; spores are cells that are 
essentially dormant (asleep) but may become 
active under certain conditions. 
ATHLETE’S FOOT (Tinea Pedis) 
BACTERIAL NAIL INFECTION 
(Paronychia) 
  
 
Athlete‟s foot (tinea pedis), also known as 
ringworm of the foot, is a surface 
(superficial) fungal infection of the skin of 
the foot. 
 
Paronychia is an infection of the skin around 
your fingernails and toenails. Bacteria or a 
type of yeast called candida typically cause 
this infection. 
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BASAL CELL CARCINOMA BEDSORES (Pressure Ulcers) 
  
 
Abasal cell carcinoma (BCC) is a type of 
skin cancer. There are two main types of 
skin cancer: melanoma and non-melanoma 
skin cancer. The commonest cause is too 
much exposure to ultraviolet (UV) light from 
the sun or from sun beds. 
 
Bedsores, also known as pressure sore, result 
from prolonged pressure that cuts off the 
blood supply to the skin, causing the skin and 
other tissue to die. 
 
CELLULITIS TINEA VERSICOLOR 
  
 
Cellulitis is an infection of the skin and is 
most often caused by the bacteria 
streptococcus or staphylococcus. 
 
The fungus Malassezia is a type of yeast 
found on the surface of the skin. It normally 
doesn‟t cause any health problems. 
CHICKENPOX CONTACT DERMATITIS 
  
  
Chickenpox, also called varicella, is 
characterised by itchy red blisters that appear 
all over the body. Varicella-zoster virus 
(VZV) causes the chickenpox infection. 
Contact Dermatitis means an inflammation of 
the skin caused by contact with something in 
the environment. Two main groups of things 
in the environment cause contact dermatitis: 
irritants and allergens. 
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DERMATOSIS PAPULOSA NIGRA  DRYSKIN 
  
Dermatosis  papulosa nigra is a harmless 
condition commonly affecting the faces of 
black and sometimes Asian adults. The cause 
of dermatosis papulosa nigra is unknown. 
Dry skin (xerosis) is a condition of rough, dry 
skin with fine scaling of skin and, ccasionally, 
with small cracks in the skin. Dry skin is 
linked to a decrease in the oils on the surface 
of the skin. 
ECZEMA (ATOPIC ECZEMA) ERYTHEMA INFECTION (Fifth) 
  
Atopic eczema is an inflammatory condition 
of the skin. In people with atopic eczema, the 
function of their skin as a barrier to the 
outside world does not work well, so that 
irritant and allergy-inducing substance enter 
their skin, and may cause dryness and 
inflammation. 
Fifth disease (erythema infectiosum), also 
called slapped-cheek disease, is a common 
illness in young children due to infection with 
parvovirus B 19. 
FUNGAL INFECTION OF NAILS MELASMA 
 
 
 
Fungal infection of the nails are also known 
as onychomycosis, as tinea unguium, and as 
ringworm of the nails. Fungi spreading from 
athlete‟s foot (known as „dermatophyte 
fungi‟) cause most fungal nail infections. 
 
 
Melasma is a common skin condition of 
adults in which light to dark brown or greyish 
pigmentation developes, mainly on the face. 
The exact cause is not known, but several 
factors contribute. These include pregnancy, 
hormonal drugs such as the contraceptive pill, 
some cosmeticsperfume can bring melasma. 
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PSORIASIS SCABIES 
  
Psoriasis is a common inflammatory skin 
disease affecting 2% of the population. It 
occurs equally in men and women, can 
appear at any age, and tends to come and go 
unpredictably. Both inherited and 
environmental factors play a role in the 
development of psoriasis. 
Scabies is a common and very itchy skin 
condition caused by human scabies mites. It 
can affect people of any age but is most 
common in the young and the elderly. 
VITILIGO TINEA FACIEI (Ringworm of face) 
 
 
Vitiligo is a common in which areas 
of skin lose their normal pigment and so 
become white. It is common, and affects 1% 
of the worlds population. The cause of 
vitiligo is not yet fully known but many 
think that it is a disease in which the body 
makes antibodies to its own melanocytes,and 
in doing so destroy them. After that, the skin 
cannot make melanin properply, and vitiligo 
is the result. 
Tinea faciei is a superficial infection 
of the skin. It is part of the dermatophyte skin 
infections and it can affect people of different 
sexes and ages. Acquired infection from pets, 
transmission one person to the other is 
possible, as the lessions are highly contagious 
to the touch. In Asia-common infection with 
trichophyton mentagrophytes and 
trichophyton rubrum. 
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THERAPEUTIC USES OF PATOLADI KVATHA CHURNA AS PER API
3,5,10
 
 Arocaka - Tastelessness 
 Chardi - Emesis 
 Jvara  - Fever 
 Kamala - Jaundice 
 Kustha - Disease of skin 
Visa  - Poison   
In order to identify the churna which is traditionally used in the treatment of skin 
disease a thorough literature survey was carried out on churnam used-traditionally for skin 
disease activity. Although many churnas are used to treat skin disease in Indian traditional 
systems of medicine, most of these churnas are not scientifically evaluated. If a systemic and 
intensive ethno pharmacological study is carried on one (or) more churnas used in traditional 
system, are sure to provide effective drug for skin diseases. 
Table 1.1 COMPOSITION OF PATOLADI KVATHA CHURNA 
(PKC)
3,5,10
 
S.NO 
NAME OF THE                     
DRUG 
BIOLOGICAL SOURCE QUANTITY/100g 
1 Kambu pudalai Leaves of Trichosanthes dioica Roxb. 
5g 
 
2 Kadugurohini 
Rhizomes of Picrorhiza kurroa Royle 
ex Benth 
5g 
3 Chandanam Heart wood of Santalum album Linn 5g 
4 Perunkurinjan 
Roots of Marsdenia tenacissima 
Wight and Arn 
5g 
5 Seenthilkodi 
Stem of Tinospora cordifolia (Willd) 
Miers 
5g 
6 Vattatiruppi Roots of Cissampelos pareira Linn 5g 
 
 
RATIONAL FOR SELECTON 
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2. RATIONAL FOR SELECTION 
An Ayurvedic formulation of Patoladi kvatha Churna were selected for the present 
work. 
As an initiative, the Ayurvedic formulation was chosen and it was standardised using 
sophisticated analytical tools. Churnam formulation was selected because further studies 
could be done to improve the patient compliance i.e., it could be formulated as a kvatha 
churna. The method of preparation of churnam is easy and it is also cost economical. 
Only initial pharmacognostical standardisation was reported in patoladi kvatha 
churna. Most of the quality control tests could be done using the various modern instruments. 
Developing a generation to prefer Ayurvedic medicines than the allopathic drugs. 
Patoladi kvatha churna has traditionally used to treat skin diseases which has not been 
proved scientifically.So, the patoladi kvatha churna has chosen to prove their activity with 
scientific evidence. 
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3. PLANT PROFILE 
Patoladi kvatha churna includes the various parts of six major crude drugs. They are 
as follows. 
Leaves of Trichosanthes dioica Roxb. 
 Rhizomes of Picrorhiza kurroa Royle ex Benth. 
 Heart wood of Santalum album Linn. 
Roots of Marsdenia tenacissima wight & Arn. 
 Stem of Tinospora cordifolia (willd) miers. 
 Roots of Cissampelos pareira Linn. 
Before starting the raw material standardisation,a short description on each plant 
covering its classification, chemical constituents and medicinal uses are given in the 
following. 
3.1 PATOLA8,9,14 
Biological Source & Family 
Trichosanthes dioica  (Cucurbitaceae) 
Synonym: Pointed Gourd, Parwal 
Scientific classification: 
Kingdom : Plantae 
Division : Magnoliophyta 
Class  : Magnoliopsida 
Order  :  Cucurbitales 
Family  : Cucurbitaceae 
Genus  : Trichosanthes 
Species : Dioica 
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Vernacular Names: 
Tamil  : Kambupudalai 
Hindi  :  Parwal 
Kannada : Thondekayi 
Telugu  : Potals 
Malayalam : Patolam 
Sanskrit      :  Potol 
Urdu           :   Parora 
Odia           :    Potala 
 
Fig 3.1 Leaves of Trichosanthes dioica 
HABITAT 
Trichosanthes dioica, a genus of family cucurbitaceae, is an annual (or) perennial 
herb distributed in tropical Asia, Polynesia, and Astralia. It is cultivated throughout the plain 
of North India. 
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BOTANICAL DESCRIPTION
9,14
 
The plant is a perennial, dioetious, and grows as a vine. Vines are pencil thick in size 
with dark green cordate,ovate, oblong, not lobed, rigid, leaves. Roots are tuberous with long 
tap root system. Flowers are tubular white with 16-19 days initiation to anthesis for pistillate 
flowers and 10-14 days for staminate flowers. Stigma remains viable for approximately 14 
hours and 40-70% of flowers set fruit. Based on shape, size, and striation, fruits can be 
grouped in to four categories, 
Long, dark green with white stripes, 10-13cm long. 
Thick, dark green with very pale green stripes, 10-16cm long. 
Roundish, dark green with white stripe, 5-8cm long. 
Tapering, green and striped, 5-8cm long. 
 
CHEMICAL COMPOSITION 
In Trichosanthes dioica, addition to a number of tetra and pentacyclic triterpenes, the 
toxic bitter principles cucurbitacines, a group of often highly oxygenated tetracyclic 
compounds with a unique carbon skeletion, and almost always a carbonyl group in ring C, 
could be consider as a taxonomic character in cucurbitaceae. The various chemical 
constituents present in Trichosanthes dioica are vitamin A, vitamin C, tannins, and Saponin. 
Seeds of Trichosanthes dioica also contain lectin, a carbohydrate (specifically galactose) & 
large amount of peptides. 
 
MEDICINAL USES 
It is highly effective in skin disease, such as Bacterial skin infection, fungal infection, 
wound healing It is also effective agents in purgative, leprosy, jaundice, fever, diabetes, 
cancer like conditions. It is a good antioxidant and blood purifier. 
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3.2 KATUKA
7,8,14
 
Biological Source & Family: It is the dried rhizomes of Picrorhiza kurroa Royle ex 
Benth. (Fam. Scrophulariaceae) 
Synonym: 
Hindi    : Kutki 
English :     Hellebore 
Scientific classification: 
Kingdom : Plantae 
Order  :  Lamiales 
Family  :  Plantaginaceae 
Genus  :  Picrorhiza 
Species :  p.kurroa 
Vernacular Names:        
Tamil  :  Kadugurohini 
Hindi         :  Kutki 
Kannada    :  Katuka rohini 
Telugu       :  Katukarohini 
Malayalam  :  Katukrohini 
Sanskrit      :  Tikta 
Urdu           :  Kutki 
HABITAT 
It is found in the Himalayan region from Kashmir to Sikkim at an elevation of 2700-
4500 and in Nepal, found abundantly between 3500 and 4800m. It is found for away from the 
community and takes from hours to days to walk to its growing habitat. 
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Fig 3.2 Whole Plant of Picrorhiza kurroa Royle ex Benth 
 
 
 
 
 
 
 
Fig 3.2A   Rhizomes of Picrorhiza kurroa Royle ex Benth 
BOTANICAL DESCRIPTION
7,8,9,14
 
Leaves: 5-15 cm long leaves, almost all at the base, often withered.Leaves are 
coarsely toothed, narrowed to a winged stalk. 
Rhizomes of the plant are 15-25 cm long and woody. 
Flowers: small,pale or purplish blue, borne in cylindric spikes, spikes borne on almost 
leafless erect stems. Flowers about 8 mm,5-lobed to the middle, and with longer stamens. 
Fruits: 1.3 cm long. 
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CHEMICAL COMPOSITION 
Chemical composition of Picrorhiza kurroa Royle ex Benth include kutkin a bitter 
glycoside which contains two C-9 iridoid glycoside-picroside 1,picrorhizin and kutakoside. 
MEDICINAL USES 
The rhizome has a long history of use in Indian Ayurvedic medicine for the treatment 
of wound healing and digestive problems. Other uses have been proposed for asthma,liver 
damage, hepatoprotective, anticholestatic, antioxidant, and immune modulating activity. 
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3.3 SVETACANDANA
7,8,10,14
 
Biological Source & Family: It is the dried heart wood of Santalum album Linn. 
(Fam.Santalaceae) 
Synonym: 
Hindi     :        Chandan 
English  :     Sandalwood 
Scientific classification: 
Kingdom : Plantae 
Order  :  Santalales 
Family  :  Santalaceae 
Genus  :  Santalum 
Species :  S. album 
Vernacular Names:        
Tamil  :  Sandanam 
Hindi  :  Safed Chandan 
Kannada :  Chand 
Telugu       :  Sriga 
Malayalam  :  Chandanam 
Sanskrit      :  Srikhanda 
Urdu           :  Sandal safed 
HABITAT 
S.album occurs from coastal dry forests up to 700 m elevation. It normally grows in 
sandy or stony red soils, but a wide range of soil types are inhabited. This habitat has a 
temperature range from 0 to 38
o
C and annual rainfall between 500 and 3000 mm.S.album can 
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grow up to 30 feet vertically.It should be planted in good sunlight and does not require a lot 
of water.The trees starts to flower after 7 years. The trunk of the tree starts to develop its 
fagrance after 10 years of growth. 
 
Fig 3.3 Heart wood of Santalum album Linn. 
BOTANICAL DESCRIPTION
7,10,14
 
The height of the evergreen tree is between 4 and 9 metres. They may live to one 
hundered years of age.The reddish or brown bark can be almost black and is smooth in young 
trees, becoming cracked with a red reveal. The heart wood is pale green to white as the 
common name indicates. The leaves are thin, opposite and ovate to lanceolate in shape. 
Glabrous surface is shiny and bright green, with a glacous pale reverse. Fruit is produced 
after three years,viable seeds after five.  
CHEMICAL CONSTITUENTS 
Chemical composition of Santalum album Linn.IncludeResin, tannic acid, volatile oil, 
β-santolol, and  santalone 
PLANT PROFILE 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 21 
MEDICINAL USES 
Sandalwood oil has been widely used in folk medicine for treatment of skin disease, 
Other uses have been proposed for treatment of common colds,bronchitis, skindisorders, 
heart ailments,general weakness, fever, infection of the urinary tract, inflammation of the 
mouth and pharynx, liver and gall bladder compliants. 
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3.4 MURVA
7,26
 
Biological Source & Family: It is the dried root of Marsdenia tenacissima Wight. 
Arn.(Fam.Asclepiadaceae) 
Synonym: 
Hindi  : Murva 
Scientific classification: 
Kingdom : Plantae 
Order  :  Gentianales 
Family  :  Apocynaceae 
Genus  :  Marsdenia 
Species : Marsdenia tenacissima 
Vernacular Names:        
Tamil  :  Perunkurinjan 
Hindi  :  Jartor 
Kannada    : Kallu shambu 
Telugu       :  Chagaveru 
Malayalam  :  Perumkurumba 
Sanskrit      :  Madhusrava 
Urdu           :  Turbud Safed 
HABITAT 
Marsdenia is a genus of plant in family Apocyanaceae first described as a genus in 
1810.The plants are native to tropical regions in Asia, Africa, Australia, and the Americas. 
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Fig 3.4 Whole Plant of Marsedenia tenacissima 
 
 
 
 
 
 
 
 
 
 
Fig 3.4A, Roots of Marsedenia tenacissima 
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BOTANICAL DESCRIPTION
7,26-27,36
 
Marsedenia tenacissima is a perennial climber with grey bark. 
Leaves are 7–15 cm long and 7–10 cm wide, broadly ovate, acuminate, deeply cordate at the 
base with rounded lobes; both surfaces are densely velvety tomentose when young, but 
become almost glabrous above when old. Petioles are pubescent and about 5–10 cm long. 
Floral characteristics 
Flowers of murva are greenish yellow, arranged in much branched,corymbose cymes. 
Calyx is deeply divided; lobes 3–4 cm in diameter, hairy outside. 
Corolla lobes are acute. Fruit is a follicle, about 10–15 cm long, paired, ovoid, lanceolate, and 
longitudinally wrinkled 
Seed are about 1–2 cm long, flattened, and ovate–oblong in shape. 
Flowering occurs in March and April, while fruits mature in May and June. 
The seeds are dispersed very frequently by splitting of fruits. 
 
CHEMICAL COMPOSITION 
Chemical composition of Marsdenia tenacissima. Include Resin, six compounds were 
isolated and their structures were identified as b-sitosterol dihydrosarcostin, daucosterol, 
condutirol, stigmasterol and 3-O-acetyl-oleanane-18-ene-3b-ol. 
 
MEDICINAL USES 
In Ayurveda, it is used in the treatment of variety of diseases such as: Fungal infection of 
Skin , Leprosy, Fever, itching, obesity, urinary disorder, intestinal parasites,piles,excessive 
thirst. purgative, alterative, and given in colic and gonorrhoea 
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PLATES  Marsdenia Tenacissima 
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3.5 GUDUCI
6,9
 
Biological Source & Family: It is the dried matured pieces of stem of Tinospora cordifolia 
(Willd).(Fam.Menispermaceae) 
Synonym: 
Hindi     :       Gurcha 
Scientific classification: 
Kingdom : Plantae 
Order  : Ranunculales 
Family  : Menispermaceae 
Genus  : Tinospora 
Species : T.Cordifoli 
Vernacular Names:        
Tamil  : Seenthil kodi 
Hindi  : Giloe 
Kannada   : Amrutaballi 
Telugu       : Thippateega 
Malayalam  : Chittamrutu 
Sanskrit : Madhuparni 
Urdu  : Gilo 
HABITAT 
Tinospora is a perennial climber found throughout Tropical India, drug collected during 
summer preferably in the month of May, drug is used in fresh form also. 
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Fig 3.5 stem of Tinospora cordifolia 
BOTANICAL DESCRIPTION
8,16
 
It is a large, deciduous extensively spreading climbing shrub with several elongated twining 
branches. Leaves simple, alternate, exstipulate, long petioles up to 15 cm long, roundish, 
pulvinate, both at the base and apex with the basal one longer and twisted partially and half 
way around. Lamina broadly ovate or ovate cordate, 10–20 cm long or 8– 15 cm broad, 7 
nerved and deeply cordate at base, membranous, pubescent above, whitish tomentose with a 
prominent reticulum beneath. Flowers unisexual, small on separate plants and appearing 
when plant is leafless, greenish yellow on axillary and terminal racemes. Male flowers 
clustered, female usually solitary. Sepals 6, free in two series of three each, the outer ones are 
smaller than the inner. Petals 6 free smaller than sepals, obovate and membranous. Fruits 
aggregate of 1-3, ovoid smooth drupelets on thick stalk with sub terminal style scars, scarlet 
or orange coloured. 
CHEMICAL COMPOSITION 
Columbin, tinosporaside, jatrorhizine, palmatine, berberine, tembeterine, tinocordifolioside, p
henylpropene disaccharides, choline, tinosporicacid, tinosporal, and tinosporon have been 
isolated from Tinospora cordifolia.  
MEDICINAL USES 
In Ayurveda, it is used in the treatment of variety of diseases such as: Skin Diseases, 
Leprosy, snake bite, malaria, dysentery, jaundice, cough. 
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3.6 PATHA
6,35
 
Biological Source & Family: Patha consists of roots of Cissampelos pareira 
Linn.(Fam.Menispermaceae) 
Synonym: 
Hindi     : Padh 
English : Velvet leaf 
Scientific classification: 
Kingdom : Plantae 
Order  : Ranunculales 
Family  : Menispermaceae 
Genus  : Cissampelos 
Species : C.pareira 
Vernacular Names:        
Tamil  : Vattathiruppi 
Hindi  : Akanadi 
Kannada : Agalushunthi 
Telugu  : Boddi tiga 
Malayalam : Patha 
Sanskrit : Ambasthaki 
HABITAT 
Cissampelosis an extensively spreading, glabrous to softy pubescent, perennial climbing 
shrub with nodose stem, common in warm and dry regions of tropical and sub-tropical parts 
of India upto an altitude of about 1500 m. 
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Fig 3.6: Whole Plant of Cissampelos pareira Linn. 
 
Fig 3.6A, Roots of Cissampelos pareira Linn. 
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BOTANICAL DESCRIPTION
6,8,34-35
 
It is a slender tomentose climber. The leaves are peltate, 2.5–12 cm long, 2.5–11.5 cm broad, 
triangularly broad-ovate, or orbicular, obtuse, mucronate, base cordate or truncate, ± 
tomentose on both sides; petiole pubescent. Flowers are small in size, pedicels filiform. Male 
flowers clustered in the axil of a small leaf; sepals are 4 in number, obovate-oblong, hairy 
outside; petals 4 in number, united to form a 4-toothed cup, hairy outside; stamens 4, column 
short, anthers connate, encircling the top of the column. Female flowers clustered in the axils 
of orbicular, hoary imbricate bracts, on 5–10 cm long racemes; sepal 1, petal 1; carpel 1, 
densely hairy; style shortly 3-fid. Drupe 4–6 mm long, 3–4 mm broad, subglobose, 
compressed, hairy-pubescent, red when fresh, black when dry, endocarp transversely ribbed, 
tuberculate. Seeds are horseshoe-shaped. 
CHEMICAL COMPOSITION 
Chemical composition of Cissampelos pareira Linn.Include Alkaloids, cissampareine, 
berberine, cissampeline, pelosine, hayantin, hayatinin, saponin and quarternary ammonium 
bases, flavonol and sterol. 
MEDICINAL USES 
The rhizome has a long history of use in Indian Ayurvedic medicine for the treatment of Skin 
diseases, itching, leucoderma, leprosy.  Other uses have been proposed for treatment of 
common colds, cough, diarrhoea,stomach disease, fever, dog bite, scorpion bite, dysentery, 
piles.  
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4. REVIEW OF LITERATURE 
Among the several Ayurvedic Churna formulations, only few were standardised and 
reported. Literature review says that only no work has been done so far in patoladi kvatha 
churnam. 
4.1 Literature review of Churnam  
 Singh Akhilesh Kumar, et al., (2011), Clinical Evaluation of Patoladi Kashaya in 
Amapachan.19 
 Shobhit Kumar, (2016),  Pharmacodynamics Study of Patoladi Kashaya and 
Karanjadi Lepa in Vicharchika w.s.r. eczema .20 
 Patel Manish, Patel Kalapi et al.,(2003), A clinico comparative study of the patoladi 
compound with and without shodhana karma (virechana karma)  in the management 
of amlapitta.21 
 Roshani Verma et al., (2015), Review on possibilities of Patoladi Gan Kashayam As 
an Adjuant therapy to combat adverse effects of Chemotheraphy/Radiotheraphy & 
Cancer.52 
 Kumar, Jitendra, Dave, et al., (2011), A comparative clinical syudy of Shatapatrayadi 
churna tablet and Patoladi yoga in the management of Amlapitta.
16 
Various other churna were reported and the reviews of those were as 
follows. 
 Rahul Raj Surisetty, Fathima Grace Xavier., et al.,(2014), standardised the Marketed 
Ayurvedic churnam formulation.
22 
 Shivani chauhen., et al., (2013), evaluated the pharmacopeial standards of 
Mahasudharshan Churna.
23 
 Shahebaz N. Ghabiyali., et al., (2012), developed the evaluation parameters for Bala 
Chaturbhadra Churna and compared it with the Market formulation.
24 
 Shailajan Sunitha., et al., (2011), standardised Trikatu churna using bio analytical 
tools.
25 
 Ajay Kr Meena, M M Rao1, et  al., (2010), Standardisation of Ayurvedic Polyherbal 
Formulation,  Pancasama Churna,
50 
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The Literature review for all the six crude drugs that are used in the formulation are given 
below. 
4.2 Literature Review of Picrorhiza kurroa  
 DeeptiRathee, et al., (2016), Phytochemical screening and antimicrobial activity 
of Picrorrhiza kurroa, an Indian traditional plant used to treat chronic diarrhea.
49
 
 P.vinotkumar,etal., (2010), In-vitro  anti-bacterial  activities  of  picrorhiza  kurroa  
rhizome extract using Agarwell diffusion method, International Journal of Current 
Pharmaceutical Research.
53
  
 Mohammed Rageeb, Mohammed Usman, et al., (2012), preliminary screening and 
antimicrobial activity of Picrorhiza kurroa royle ethanolic extracts.
54
 
 Vijender Singh, Ashok Chaudhary, et al., (2012),“Anti-hyper lipidemic activity of 
Picrorhiza kurroaRoyle ex Benth Roots”.55 
 Acharya Balkrishna, Hemanth Kumar Manikyam, et al.,(2016), Clastogenic effect of 
Picrorhiza kurroa rhizome extract on cultured human peripheral blood lymphocytes.
56 
 K. Kant, M. Walia,  et al., (2013), Evaluation of Antioxidant Activity of Picrorhiza 
kurroa (Leaves) Extracts.
57 
 Arshad Hussain, Wahab Shadma, et al., (2013), Protective effects of Picrorhiza 
kurroa on cyclophosphamide-induced immunosuppression in mice.
58
 
 P. Vinothkumar, A. Sivaraj, et al., (2010), Hepatoprotective and antioxidant 
properties of aqueous rhizome extracts of Picrorhiza kurroa on CCl 4 induced liver 
toxicity in albino rats.
86 
4.3 Literature Review of Cissampelos Pareira 
 Hema.T.A, Arya. A.s, et  al., (2013),  Antimicrobial activity of five south indian 
medicinal Plants against clinical pathogens.
48 
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5. AIM AND OBJECTIVE OF THE STUDY 
Thousands of floras have been studied and screened for various activities. But still 
most of them remain only in the textual form. No steps have been taken to apply those 
research works and make them useful to the poor and diseased. 
The aim of the work is to uplift the traditional system of medicine by using the 
modern standardisation techniques. The wealth of our mother nation should be utilised by us. 
Future research must focus towards herbal drugs and their improvement. 
The main objective to choose a churnam formulation is to create awareness among the 
people regarding the usage of Ayurvedic Medicine. Strict guidelines to be brought to 
formulate any herbal medicine. All the methods of standardisation given in the scriptures and 
books should be explored. 
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6. PLAN OF WORK 
1. Selection of a Churnam formulation based on survey among Ayurvedic physicians 
and from the available literature. 
 
2. Collection, Herbarium preparation and authentication of raw materials taxonomically. 
 
3. Standardisation of raw materials 
a) Morphology 
b) Powder Microscopy 
c) Physico-chemical analysis 
i. Foreign Organic Matter 
ii. Ash Values 
iii. Extractive Values 
iv. Loss on Drying 
 
4. Formulation of Churnam 
 
5. Standardisation of formulated churnam using the modern techniques as 
a) Morphology 
b) Powder Microscopy 
c) Fluorescence analysis 
d) Physico-chemical analysis 
i. Ash Values 
ii. Extractive Values 
iii. Loss on Drying 
 
6. Toxicological/safety profile evaluation of Churnam 
a) Determination of Microbial contamination as per WHO Specifications(TFC,TBC) 
b) Determination of heavy metals (Pb,Cd,Ar, Hg) 
c) Determination of Pesticide Residue 
d) Total Aflatoxin Content (GC) 
e) Estimation of Sodium by Flame Photometry 
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7. Phytochemical standardisation 
a) Qualitative Phytochemical Screening 
b) Quantitative Phytochemical Screening 
 
8. Phyto analytical standardisation 
a) TLC studies 
b) HPTLC studies 
c) GC-MS analysis 
 
9. Pharmacological studies 
a) In-vitro anti-bacterial and anti-fungal activity  
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7. MATERIALS AND METHODS
6,7
 
Patoladi kvatha churna is a powder dosage form used in Ayurvedic system of 
Medicine.On ethno medical survey among the Ayurvedic physicians, it is revealed that the 
formulation is widely prescribed for its skin disease activity. As per API, it has been observed 
that it could be given to treat skin diseases. Though PKC was into practise, the formulation 
have not yet standardised completely and using composition of patoladi kvatha churna is not 
coming under the sarngadhara-samhita. 
Table 7.1 Composition of Patoladi Kvatha Churna (PKC)
3,5,10
 
S.NO 
NAME OF 
THE                     
DRUG 
BIOLOGICAL SOURCE 
QUANTITY/
100g 
1 Kambu pudalai Leaves of Trichosanthes dioica Roxb. 5g 
2 Kadugurohini Rhizomes of Picrorhiza kurroa Royle ex Benth 5g 
3 Chandanam Heart wood of Santalum album Linn 5g 
4 Perunkurinjan Roots of Marsdenia tenacissima Wight and Arn 5g 
5 Seenthilkodi Stem of Tinospora cordifolia (Willd) Miers 5g 
6 Vattatiruppi Roots of Cissampelos pareira Linn 5g 
 
COLLECTION AND AUTHENTICATION OF THE INGREDIENTS OF PKC 
Leaves of Trichosanthes dioica Roxb, Rhizomes of Picrorhiza kurroa Royle ex Benth, 
Heart Wood of Santalum album Linn, Roots of Marsdenia tenacissima Wight and Arn, Stem 
of Tinospora cordifolia (willd) Miers and Roots of Cissampelos pareira Linn were collected 
from various parts of the Indian states in the month of August – 2017. Three plants were 
authentified by Dr.P.SATHYARAJESWARAN, Assistant Director (Scientist -2), Central 
Siddha Research Institute, Govt. Of India, Arumbakkam, Chennai. Another three plants were 
authentified by Dr.R.Ilavarasan, Assistant Director (Scientist -3) Incharge, Regional 
Ayurveda Drug Development Institute, Ministry of Ayush, Govt. of India, Arumbakkam, 
Chennai. 
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7.1 PHARMACOGNOSTICAL STANDARDIZATION OF RAW 
MATERIALS 
MORPHOLOGICAL STUDIES
6,7
 
The morphological examination of Leaves of Trichosanthes dioica Roxb, Rhizomes of 
Picrorhiza kurroa Royle ex Benth, Heart Wood of Santalum album Linn, Roots of Marsdenia 
tenacissima Wight and Arn, Stem of Tinospora cordifolia (willd) Miers and Roots of 
Cissampelos pareira Linnwas done by observing the sample collected in naked as well as 
luminescent light for their colour, size and shape. The odour and taste of the material were 
also studied. All these observations were noted and given in the result section. 
POWDER MICROSCOPICAL STUDIES 
The Leaves of Trichosanthes dioica Roxb, Rhizomes of Picrorhiza klurroa Royle ex 
Benth, Heart Wood of Santalum album Linn, Roots of Marsdenia tenacissima Wight and Arn, 
Stem of Tinospora cordifolia (willd) Miers and Roots of Cissampelos pareira Linn were dried 
for a minimum of the 15 days under shade, powdered and passed though sieves with aperture 
size of 180µm and 125µm separately to obtain fine and very fine powers respectively. The 
powder were subjected to Microscopical examination. The specimens were treated with the 
following reagents on order to evaluate components of diagnostic value: 50% glycerine as 
temporary mountant:2% Phloroglucinol in a mixture of 90% ethanol and conc. HC1 (1:1) for 
lignin:5% alcoholic ferric chloride for phenol compounds:2% iodine solution for starch 
grains; 0.08% ruthenium red in 10% lead acetate for mucilage and Sudan III red for oil 
globules. 
FLUORESCENCE ANALYSIS
111-112
 
A molecule can be excited from its ground electronic state to an excited electronic 
state by absorbing energy in the form of visible or ultraviolet light. Many molecules are 
capable of emitting this energy as radiation, thus returning to the ground state. The emitted 
radiation is called fluorescence. For fluorescence analysis the whole plant powder was treated 
with different solvents (1N aqueous sodium hydroxide and IN alcoholic sodium hydroxide, 
acids like 1N hydrochloric acid, 50% Sulphuric acid) separately and then these extracts were 
subjected to fluorescence analysis in visible/day light and UV light in 254nm and in 365nm. 
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7.2 PHYSICO-CHEMICAL ANALYSIS
6,7
 
DETERMINATION OF ASH VALUES 
 The residue remaining after incineration is the ash content of the drug, which simply 
represent the inorganic salts naturally occurring in the drug or adhering to it or deliberately 
added to it as a form of adulteration. For determining ash, the powdered drug is incinerated so 
as to burn out all organic matter. 
TOTAL ASH 
 Silica crucible was heated to red hot for 30 minutes and it was allowed to cool in 
desiccators. About 2gm of powdered sample was weighted accurately and evenly distributed 
in the crucible. Dried at 100 - 150°C for 1 hour and ignited to constant weight in a muffle 
furnace at 600±25°C. The crucible was allowed to cool in a desiccators. The percentage yield 
of ash with reference to the air dried substance was then calculated. 
WATER SOLUBLE ASH 
 The total ash was boiled for 5min with 25ml of water. The insoluble matter was then 
collected in an ash less filter paper. It was washed with hot water and ignited for 15min at a 
temperature not exceeding 450°C. The weight of the insoluble matter was subtracted from the 
weight of the ash and the difference in weight represented the water soluble ash, the 
percentage of water soluble ash with reference to the air dried substances was calculated. 
ACID INSOLUBLE ASH 
 Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid and igniting the remaining insoluble matter. This measures the amount of 
silica present, especially as sand and siliceous earth. 
Procedure 
 To the crucible containing total ash of the sample, 25 ml of dilute hydrochloric acid is 
added. The insoluble matter is collected on an ashless filter paper (Whatman  41) and washed 
with hot water until the filtrate is neutral, Filter paper containing the insoluble matter to the 
original crucible, dry on hot plate and ignite to constant weight. Allow the residue to cool in a 
suitable desiccators for 30 minutes and weighed without delay. Content of acid-insoluble ash 
with reference to the air dried drug is calculated. 
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  Acid insoluble ash = Weight of the residue obtained X 100 
     Weight of the sample taken 
 
DETERMINATION OF EXTRACTIVE VALUES 
 This method is used to determine the amount of active constituents in a given amount 
of plant material when extracted with solvents. Extractive values are useful for the evaluation 
of phytoconstituents especially when the constituents of a drug cannot be readily estimated 
by any other means. Further these values indicate the nature of the active constituents present 
in a crude drug. 
DETERMINATION OF WATER SOLUBLE EXTRACTIVE 
 About 5gm of the powder was weighed and macerated with 100ml of chloroform 
water (95ml distilled water and 5ml chloroform) in a closed flask for 24 hours. It was shaken 
frequently for six hours and allowed to stand for eighteen hours. I was then filtered rapidly, 
taking precautions against loss of solvent and 25ml of the filtrate was evaporated to dryness 
in a tarred flat bottomed shallow dish. 2 ml of alcohol was added to the residue and it was 
dried at 105°C for 1 hour in the hot air oven and cooled in desiccators for 30min. and weight. 
The process was repeated till a constant weight was obtained; the percentage of water soluble 
extractive value with reference to the air dried drug was calculated. 
DETERMINATION OF ALCOHOL SOLUBLE EXTRACTIVE 
 The alcohol soluble extractive value is also indicative for the same purpose as water 
soluble extractive value. The solvent strength of alcohol varies from 20 - 90%v/v. The 
solvent strength has to be chosen depending upon the strength of alcohol used for the 
extraction of powered drug. 
Procedure 
 About 5gm of the powder was weighed and macerated with 100ml 90% ethanol in a 
closed flask for 24 hours. It was shaken frequently for six hours and allowed to stand for 
eighteen hours. It was then filtered rapidly, taking precautions against loss of solvent and 
25ml of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish. It was 
dried at 105
o
 C for 1 hour in hot air oven. The dish was cooled in desiccators and weighed. 
The process was repeated till the constant weight was obtained. The percentage of alcohol 
soluble extractive value will reference to the air dried drug was calculated. 
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DETERMINATION OF LOSS ON DRYING 
 10g of drug was accurately weighed and placed it in a tared evaporating dish. After 
placing the drug in the tared evaporating dish it was dried at 105°C for 5 hours, and weight. 
The drying was continued and weight at one hour interval until difference between two 
successive weighing corresponds to not more than 0.25 percent. Constant weight is reached 
when two consecutive weighing after drying for 30 minutes and cooling for 30 minutes in a 
desiccators, show not more than 0.01g difference.  
DETERMINATION OF VOLATILE OIL 
 The determination of volatile oil in a drug is made by distilling the drug with a 
mixture of water and glycerin, collecting the distillate in a graduated tube in which the 
aqueous portion of the distillate is automatically separated and returned to the distilling flask, 
and measuring the volume of the oil. The content of the volatile oil is expressed as a 
percentage v/w. 
7.3 FORMULATION OF PATOLADI KVATHA CHURNA
3,5,10 
 
Table 7.2 Composition of Patoladi Kvatha Churna (PKC) 
 
S.NO 
NAME OF THE                     
DRUG 
BIOLOGICAL SOURCE 
QUANTITY/
100g 
1 Kambu pudalai Leaves of Trichosanthes dioica Roxb. 5g 
2 Kadugurohini Rhizomes of Picrorhiza kurroa Royle ex Benth 5g 
3 Chandanam Heart wood of Santalum album Linn 5g 
4 Perunkurinjan Roots of Marsdenia tenacissima Wight and Arn 5g 
5 Seenthilkodi Stem of Tinospora cordifolia (Willd) Miers 5g 
6 Vattatiruppi Roots of Cissampelos pareira Linn 5g 
 
METHOD OF PREPARATION 
 All the ingredients were taken as per Pharmacopoeial quantity as listed under table 7.2 
was roasted in a stainless steel pan at a low temperature till it becomes free from moister. All 
the ingredients were powdered individually in a pulverizer. Each ingredient was weighed 
separately, mixed together in specified ratio to obtain a homogenous blend. The churnam was 
packed in a tightly closed container to protect from light and moisture. 
Dosage: 40ml two times a day for 21 days. 
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Standardization of formulation 
 The prepared in-house Patoladi Kvatha Churna formulation has been standardized as 
per WHO guidelines under the various headings using standard protocol obtained from 
Ayurvedic Pharamacopoeia of India, Herbal Pharmacopoeia, Herbal compendium, reference 
books and official agency guidelines. 
7.4. SAFETY PROFILE/TOXICOLOGICAL EVALUATION 
 The formulated Churnam was subjected to toxicological evaluation in order to ensure 
the safety profile of the formulation. 
DETERMINATION OF MICROBIAL CONTAMINATION
113
 
 Since it became known in 1960’s that patience could contract serious infections from 
oral and ophthalmic drugs contaminated with Salmonella and Pseudomonas, great efforts 
have been made both by scientist and by the authorities to put limitations on the degree of 
microbial contamination, even in medicinal preparations which do not obligatorily need to be 
sterile. The principal demand is for the demonstrated absence of pathogenic bacteria and so 
called indicator bacteria, example Escherichia Coil. 
 The permitted number of pathogenic bacteria in oral medicaments is very much lower 
than in foodstuffs and should perhaps relate to the finished product. The limit in natural 
starting materials should be 10
4
 bacteria/g and 100 mould or yeast cells/g, especially when a 
reduction of the number of organisms can be expected from further processing. 
Sample Preparation: 
10g of sample is dissolved in 90 ml of Sodium chloride peptone solution to prepare 
1:10 dilution or to make further suitable dilutions. 
Tests for Total Viable Aerobic Count (Total bacterial load, Total fungal count) 
1. 1 ml of prepared sample is transferred in duplicate to the two sets of plates. 
2. Around 20 ml of Soyabean Casein Digest Agar was poured aseptically in two plates 
and Sabouraud Dextrose Agar was poured in another two plates. 
3. Mixed well to distribute the sample properly and allowed the medium to solidify. 
4. Inverted the plate and incubated the plates of Soyabean Casein Digest Agar at 30 – 
35
o
C for 3 days and sabouraud Dextrose Agar at 20 - 25
o
C for 5 days. 
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5. After completion of incubation period the numbers of colonies were observed on 
plates were counted. 
6. Enumerate the counts as cfu/g by using the formula given below 
No. of colony forming units on plate x Dilution factor 
The mean of two plates for both SCDA and SDA were taken and reported the counts 
on SCDA as Total Viable Aerobic Counts and the counts on SDA as total yeast and mold 
counts. 
Total for Escherichia coil 
1. Sample was prepared using a 10 fold dilution of not less than 1 g of the products to be 
examined in sodium in sodium chloride peptone solution. 
2. 3 tubes of suitable quantity of soyabean casein digest broth were prepared. 
3. Transferred quantities corresponding to 0.1 g, 0.01 g and 0.001 g to the tubes of 
soyabean casein digest broth. 
4. Mixed and incubated at 30 - 35oC for 18-24 hrs.  
5. Shook all the tubes and tranfered 1 ml from each tube to 100 ml of MacConkey broth 
and incubated 42 – 44oC for 18 – 24 hrs. 
6. Subcultured from MacConkey broth to plates of MacConkey agar and incubated at 30 
- 35
o
C for 18-72 hrs. 
7. Growth of colonies indicates the possible presence of E.coli. This was confirmed by 
identification test. 
8. Noted the smallest quantity of the product that gives a positive result and the largest 
quantity that gives a negative result. 
9. The probable number of bacteria from the following table was determined. 
Test for Salmonella spp. 
1. Enrichment was done by transferring 1 gm of the sample into 10ml of selenite 
cysteine broth. 
2. Incubated for 24 hr at 37oC. 
3. The enriched culture after incubation was then streaked on duplicate plates of freshly 
prepared Bismuth, Sulphite Agar (BSA), (one lightly and one heavily), and incubated 
alone with the control plate Bismuth Sulphite Agar (BSA) at 37
o
C for 24 hr. 
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4. After incubation, typical black and green colonies were regarded as positive for 
Salmonella. 
5. The colonies were then streaked on the nutrient agar slants for further biochemical 
identifications using Triple Sugar Iron (TSI) and Lysine Iron Agar (LIA) tests. 
DETERMINATION OF HEAVY METALS
114
 
Heavy metal analysis (Lead, Cadmium, Mercury and Arsenic) 
The medicinal plant materials can be contaminated with arsenic and heavy metals 
which can be attributed to many causes including environmental pollution and places of pesticides. 
As these components even in trace amounts are dangerous, they have to be removed from the 
herbal drugs. Limit for these materials have been prescribed in almost all the Pharmacopoeia 
throughout the world. As prescribed by WHO, the following procedures have been recommended 
for their respective limit tests. 
Determination of Lead: 
Instrument: AAS with Graphite Furnace and Microwave Reaction System Reagents 
and Standard: 
 Nitric Acid Ultra Pure grade 
 Magnesium nitrate Hexahydrate AR grade 
 Ammonium dihydrogen phosphate AR grade 
 Hydrogen Peroxide 
 Milli Q water 
 Lead standard 1000 ppm 
Preparation of reagents: 
Diluents (0.5% v/v nitric acid): 
5 ml of nitric acid was diluted to 1000 ml with water. 
Matrix modifier: 
About 0.20 g of ammonium dihydrogen phosphate and 0.01 g of magnesium nitrate 
Hex hydrate is weighed and transferred accurately to a 100 ml volumetric flask, dissolved in and 
made up the volume with diluents and mixed. 
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Standard Preparation (30 ppb Pb): 
1. 0.25 ml of Lead standard solution (1000 ppm Pb) is transferred accurately to a 250 ml 
volumetric flask and mixed, made up the volume with diluents. 
2. 0.75 ml of the resulting solution was transferred to a Teflon tube, added 4 ml of nitric 
acid I ml hydrogen peroxide sol. (30%) and digested in microwave reaction system as 
per microwave parameters. 
3. Transferred the resulting digested solution to a 25 ml volumetric flask, rinsed the tube 
with 10 ml of diluents and transferred it to the same volumetric flask, and made up to 
volume with diluents and mixed. 
Test preparation: 
1. About 0.05 g of the test sample was taken in a Teflon tube. 4 ml of nitric acid and 1ml 
hydrogen peroxide sol. (30%) was added and digested in microwave reaction system 
as per microwave parameters given under. 
2. Transfered the resulting digested solution to a 25 ml volumetric flask, rinsed the tube 
with 10 ml of diluent and transferred it to the same volumetric flask and made up to 
volume with diluents and mixed. 
Reagent blank: 
1. Transferred 4 ml of nitric acid and 1 ml hydrogen peroxide sol. (30%) to a Teflon 
tube and digested in microwave reaction system as per microwave parameters given 
under. 
2. Transferred the resulting digested solution to a 25 ml volumetric flask, rinsed the tube 
with 10 ml of diluent and transferred it to the same volumetric flask and made up to 
volume with diluent and mixed. 
Instrumental parameters: 
Table 7.3 Microwave parameters for determination of Lead 
S.No. Power Ramp 
Hold time 
(min.) 
Fan 
1 1000 10 30 1 
2 0 0 15 3 
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AAS (with Graphic furnace) Parametes: 
Spectrometer:- 
Lamp Setting 
Element: Lead, Wavelenth: 283.31 nm, Slit width: 2.7/1.05nm, Signal type: AA-BG, 
Measurement: Peak Area 
Read parameter setting:- 
Read time: 5 Seconds, Delay time: 0 Seconds, BOC time: 2 Seconds, 
Replicate: 3 (Same for all samples), Calibration equation: Linear through Zero, 
Units:- Calibration: µg/L, Sample:µg/L. 
1. Graphite Furnace:- 
 
Table 7.4 Temperature programming for determination of Lead 
Step 
Temp 
o
C 
Ramp 
time 
(Sec.) 
Hold time 
(Sec.) 
Gas flow 
(ml/min.) 
Gas type 
1 100 5 20 250 Normal (Argon) 
2 140 15 15 250 Normal (Argon) 
3 700 10 20 250 Normal (Argon) 
4 2300 0 5 0 Normal (Argon) 
5 2600 1 3 250 Normal (Argon) 
 
Read step 4 
Auto sample parameter:- 
Sample Volume: 25µl 
Volume of matrix modifier: 20µl 
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Standard Preparation (30 ppb Pb) 
volume (in µL) 
5 10 15 20 25 
Volume of diluent (in µL) 20 15 10 5 0 
Std conc. Obtained (in ppb) 6 12 18 24 30 
 
Procedure: 
1. Introduced diluent (as blank) into the atomic generator for auto zero. 
2. Introduced each of the reference solutions in triplicate and recorded the steady 
reading. Drew linearity curve (linear through zero). 
3. Introduced the reagent blank into the atomic generator for auto zero. 
4. Introduced the test solution in triplicate into atomic generator and recorded the steady 
reading. 
5. Calculated the linear equation of the graph using least-squares fit and derived from it 
the conc. (C) of lead in the test solution in µg/L. 
Note: Coefficient of determination should not be less than 0.95. The LOQ of the Method 
is 2.6 ppb in test solution. 
Calculation: 
         Tc  25 
   Lead (in ppm) = ----------- x ------------- 
      1000  WT 
Where, 
TC =Average conc. (ppb) found in test. 
WT = Weight of test sample taken (in g) 
Determination of Cadmium: 
Instrument : AAS with Graphite Furnace and Microwave Reaction System Reagents 
and Standard 
 Nitric acid grade (Make Merck) 
 Magnesium nitrate Hexahydrate AR grade 
 Ammonium dihydrogen phosphate AR grade 
 Hydrogen Peroxide Sol. (30%) 
 Mili Q Water  
 Cadmium Standard above 99% purity 
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Preparation of reagents: 
Diluent (0.5% v/v nitric acid): 
 Diluted 5 ml of nitric acid to 1000  ml with water. 
Matrix modifier: 
Weigh and transfer accurately about 0.20 g of ammonium dihydrogen phosphate and 
0.05 g of magnesium nitrate Hexahydrate were weighed accuratetly & transferred to a 100 ml 
volumetric flask dissolved in and made up the volume with diluent and mixed. 
Standard preparation (1.125 ppb Cd): 
1. Weighed and transfered accurately 0.100 g of Cadmium Standard to a 100 ml 
volumetric flask, dissolved in 3 ml nitric acid and 3 ml water and made up the volume 
with diluent. 
2. Transfered 0.1 ml of the resulting solution to 100 ml with diluent and mixed. 
3. Further, diluted 5 ml of the above resulting solution to 50 ml with diluent and mixed. 
4. Transfered 0.225 ml of the above solution to a Teflon tube, added 4 ml of nitric acid 
and 1 ml hydrogen peroxide sol. (30%) and digested in microwave reaction system as 
per microwave parameters given under. 
5. Transfered the resulting digested solution to a 20 ml volumetric flask, rinsed the tube 
with 10 ml of diluent and transfered it to the same volumetric flask and made up to 
volume with diluents and mixed. 
Test preparation: 
1. Weighed and transfered accurately about 0.05 g of the test sample to a Teflon tube. 
2. Added 4 ml of nitric acid and 1 ml hydrogen peroxide sol. (30%) and digested in 
microwave reaction system as per microwave parameters given under. 
3. Transfered the resulting digested solution to a 20 ml volumetric flask, rinsed the tube 
with 10 ml of diluent and transfered it to the same volumetric flask and made up to 
volume with diluent and mixed. 
Reagent blank: 
1. Transfered 4 ml of nitric acid and 1 ml hydrogen peroxide sol. (30%) to ateflon tube 
and digested in microwave reaction system as per microwave parameters given under. 
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2. Tranfered the resulting digested solution to a 20 ml volumetric flask, rinsed the tube 
with 10 ml of diluents and tranfered in to the same volumetric flask and made up to 
volume with diluents and mixed. 
 
Table 7.5: Microwave Parameters for Determination of Cadmium 
S.No. Power Ramp 
Hold time 
(min.) 
Fan 
1 1000 10 30 1 
2 0 0 15 3 
 
AAS (With Graphite Furnance) 
Parameters: 
Spectrometer:- 
Lamp Setting 
Element : Cadmium, Wavelength : 228.80 nm, Slit width : 1.8/0.06nm, Signal type: AA-BG, 
Measurment: Pack Area. 
Read Parameters setting:- 
Read time: 5 Seconds, Delay time : 0 Seconds, BOC time : 2 Seconds. 
Replicate : 3 (Same for all samples), Calibration equation : Linear through Zero. 
Units:- 
Calibration : µg/L, Sample : µg/L. 
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2.Graphite Furnace:- 
Table 7.6 Temperature programming for determination of Cadmium 
Step 
Temp 
o
C 
Ramp 
time 
(Sec.) 
Hold time 
(Sec.) 
Gas flow 
(ml/min.) 
Gas type 
1 100 5 20 250 Normal (Argon) 
2 140 15 15 250 Normal (Argon) 
3 650 10 20 250 Normal (Argon) 
4 1350 0 5 0 Normal (Argon) 
5 2600 1 3 250 Normal (Argon) 
 
Read step 4 
Auto sampler parameter:- 
Sample volume : 25µl 
Volume of matrix modifier : 7 µl 
Standard Preparation (1.125 ppb 
Cb) volume (in µl) 
5 10 15 20 25 
Volume of diluent (in µL) 20 15 10 5 0 
Std conc. Obtained (in ppb) 0.225 0.450 0.675 0.90 1.125 
 
Procedure:- 
1. Introduced diluents (as blank) into the atomic generator for auto zero. 
2. Introduced each of the reference solutions in triplicate and recorded the steady 
reading. Draw linearity curve (linear through zero). 
3. Introduced the reagent blank into the atomic generator for auto zero. 
4. Introduced the test solution in triplicate into atomic generator and recorded the steady 
reading. 
5. Calculated the linear equation of the graph using a least-square fit and derived from it 
the conc. (C) of Cadmium in the test solution in µg/L. 
Note: Coefficient of determination should not be less than 0.95. The LOQ of the method 
is 0.06 ppb in test solution. 
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Calculation:  
      Tc  25 
   Lead (in ppm) = ----------- x ------------- 
      1000  WT 
 
Where, 
TC  =Average conc. (ppb) found in test. 
WT  =Weight of test sample taken (in g). 
Determination of Mercury: 
Instrument: AAS with FIAS flame and Microwave Reaction System Reagents and 
Standard 
 Hydrochloric acid ultrapure grade (Make Merck) 
 Potassium Permanganate AR grade 
 Ascorbic acid AR grade 
 Nitric acid ultrapure grade (Make Merck) 
 Hydrogen Peroxide Sol. (30%) AR grade 
 Sodium borohydride AR grade 
 Sodium Hydroxide AR grade 
 Milli Q water 
 Mercury Standard Solution 10 ppm 
Preparation of reagents: 
Diluent : Water 
Martrix modifier (5% KMnO4): 
 Weighed and transfered accurately about 0.5 g of potassium permanganate to a 10 ml 
Volumetric flask dissolved in and made up the volume with diluent and mixed. 
0.01% Sodium hydroxide: 
 Weighed and transfered accurately about 0.1 g of sodium hydroxide in a 1000 ml 
volumetric flask dissolved in and made up the volume with water and mixed. 
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0.2% Sodium borohydride in 0.01% Sodium Hydroxide (Reductant solution): 
 Weighed and transfered accurately about 2.0 g of sodium borohydride and 1.0 g of 
ascorbic to a 1000 ml volumeric flask dissolved in and made up the volume with 0.01% 
sodium hydroxide and mixed. 
3% Hydrochloric acid (Carrier solution): 
 To 500 ml water, added 30 ml of Hydrochloric acid and made up the volume with 
water to 1000 ml. 
Stock standard preparation (100 ppb Hg) 
 Transfered accurately 1 ml of Mercury Standard Solution (10 ppm Hg) solution to a 
100 ml volumetric flask, added 50 ml diluents and 1 ml of nitric acid mixed in and made up 
the volume with diluents. 
Linearity standard preparations: 
1. Transfered accurately 0.5, 1.0, 1.75, 2.50 and 3.25 ml of the above stock standard 
preparation (100 ppb Hg) to separate teflon tubes. To each of the Teflon tube added 4 
ml nitric acid and 4 ml hydrogen peroxide solution 30% and digested in microwave 
reaction system as per microwave parameters given under. 
2. Transfered each of the digested standard preparations to separate 25 ml volumetric 
flasks, rinsed the Teflon tubes with 5 ml diluent and tranfered to the respective 
volumetric flasks. To each of volumetric flasks, added 0.4 ml of hydrochloric acid, 
and 20 µL of matrix modifier and made up to volume with diluents to obtain linearity 
standard solutions having come. Of 2, 4,7, 10 and 13 ppb of Hg respectively. 
Test preparation: 
1. Weighed and tranfered accurately about 0.20g of the test sample to Teflon tube. To 
the Teflon tube added 4 ml nitric acid and 4 ml hydrogen peroxide solution 30% and 
digested in microwave reaction system as per microwave parameters given under. 
2. Tranfered the digested solution to a 25 ml volumetric flask. Rinsed the Teflon tube 
with 5 ml diluents and tranfered to the volumetric solution. To it, added 0.4 ml of 
hydrochloric acid, and 20 µL of matrix modifier and made up to volume with 
diluents. 
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Reagent Blank: 
1. Tranfered 4 ml of nitric acid and 4 ml of hydrogen peroxide to Teflon tube and 
digested in microwave reaction system as per microwave parameters given under. 
Tranfered the digested solution to a 25 ml volumetric flask. Rinsed the Teflon tube with 5 ml 
diluent and tranfered to the volumetric solution. To it, added 0.4 ml of hydrochloric acid, and 
20 µL of matrix modifier and made up to volume with diluents. 
Instrumental parameters: 
Table 7.7 Microwave parameters for determination of Mercury 
S.No. Power Ramp 
Hold time 
(min.) 
Fan 
1 1000 10 30 1 
2 0 0 15 3 
 
AAS (with FIAS Flame) parameters: 
a. Spectrometer:- 
(i) Lamp setting 
Element : Mercury, Wavelength: 253.65 nm, Slit width : 2.7/1.05 nm, Signal type: AA 
Measurements : Peak Height. 
(ii) Read parameter setting:- 
Read time: 25 Seconds, Delay time: 0 Seconds, BOC time : 2 Seconds, Replicate : 3 
(Same of all samples), Calibration equation : Linear through Zero. 
Units:- 
Calibration : µg/L, Sample : µg/L. 
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Table 7.8 FIAS programming for determination of Mercury 
Step Time Sec.  Pump 1 speed Pump 2 
Speed  
Value Position 
Pre – fill 15 120 0 Fill 
1 20 120 0 Fill 
2 30 120 0 inject 
 
Read Step 2 
Sample Volume : 50 µl. 
Gas flow (Argon) : 150 ml/min. 
Flame Programme:- Flame off. 
Procedure: 
1. Dipped the line of reductant in reductant solution (0.2% sodium borohydride in 0.01% 
sodium hydroxide) and line of carrier in carrier solution (3% Hydrochloric acid) and 
ran programme as given in FIAS programming. 
2. Introduced each blank (s blank) into the atomic generator for auto zero. 
3. Introduced each of the reference solution in triplicate and recorded the steady reading. 
Draw linearity curve (linear through zero). 
4. Introduced the reagent blank into the atomic generator for auto zero. 
5. Introduced the test solution in triplicate into atomic generator and recorded the steady 
reading.  
6. Calculated the linear equation of the graph using a least - squares fit and derived from 
it the conc. (C) of Mercury in the test solution in µg/L. 
Note: Coefficient of determination should not be less than 0.95. 
The LOQ of the method is 1.9 test solution 
 
Calculation:     Tc  x  25 
  Mercury (in ppm) = -------------------------- 
      1000  x WT 
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Where,  
 Tc  = Average conc. (ppb) found in test. 
 WT = Weight of test sample taken (in g). 
Determination of Arsenic 
 Arsenic is abundant in nature and its presence in herbal medicines should be no 
different to its wide occurrence in foods. A popular test method relies on the digestion of the 
plant matrix followed by subjection of the digestate to a comparative colorimetric test in a 
special apparatus. 
 The test method described below uses colorimetry and does not use toxic mercuric 
bromide paper. The method uses N-N-diethyl methyl-di-thiocarbamate in pyridine and it 
reacts with hydrogen arsenide to afford a red – purple complex. The limit is expressed in 
terms of arsenic (III) trioxide (As2O3). 
Procedure 
 Placed glass wool in the exit tube B up to about 30 mm in height, moistened the glass 
wool uniformly with a mixture of an equal volume of lead (II) acetate and water, and applied 
gentle suction to the lower end to remove the excess mixture. Inserted the tube vertically into 
the center of the rubber stopper, and attached the tube to the generator bottle so that the small 
perforation in the lower end extends slightly below the stopper. At the upper end attached the 
rubber stopper to hold the tube vertically, Made the lower end of the exit tube level with that 
of the rubber stopper. 
Preparation of the test solution 
Method 
Weighed the specified amount of the sample and placed it in a crucible of porcelain. 
Added 10 ml of a solution of magnesium nitrate hexahydrate in 9 5 %   ethanol, burned the 
ethanol, heated gradually, and ignited to incinerate. 
After cooling, added 3 ml of hydrochloric acid, heated in a water bath to dissolve the 
residue, and designated it as the test solution. 
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Standard solutions 
 Absorbing solution for hydrogen arsenide. Dissolved 0.50 g of silver N.yV-diethyl-
dithiocarbamate in pyridine to   made 100 ml. Preserved this solution in a glass-
stoppered bottle protected from light, in a cold place. 
 Standard arsenic stock solution. Weigh accurately 0.100 g of finely powdered arsenic 
(III) trioxide standard reagent dried at 105 °C for 4 hours, and added 5 ml of sodium 
hydroxide solution (1 in 5) to dissolve. Added dilute sulfuric acid to neutralize, added 
a further 10 ml of dilute sulfuric acid and added freshly boiled and cooled water to 
made exactly 1000 ml. 
 Standard arsenic solution. Pipetted 10 ml of standard arsenic stock solution, added 10 
ml of dilute sulfuric acid and added freshly boiled and cooled water to made exactly 
1000 ml. Each ml of the solution contains lµg of arsenic (III) trioxide (AS2O3). 
Prepared standard arsenic solution just before use and preserved in a glass-stoppered 
bottle. 
Procedure 
Placed the test solution in the generator bottle and wash down the solution in the 
bottle with a small quantity of water. Added 1 drop of methyl orange, and after neutralizing 
with ammonia, added 5 ml of diluted hydrochloric acid (1 in 2) added 5 ml of potassium 
iodide, and allowed to stand for 2 to 3 minutes. Added 5 ml of acidic tin (II) chloride and 
allowed to stand for 10 minutes. Then added water to make 40 ml, added 2 g of zinc for 
arsenic analysis and immediately connected the rubber stopper fitted. 
Preparation of standard colour. 
Measured accurately 2 ml of Standard Arsenic Solution into the generator bottle. 
Added 5 ml of diluted hydrochloric acid (1 in 2) and 5 ml of potassium iodide and allowed to 
stand for 2 to 3 minutes. Added 5 ml of acidic tin (II) chloride, allowed to stand at room 
temperature for 10 minutes and then proceeded as directed above. The colour produced 
corresponds to 2 pg of arsenic (III) trioxide (AS2O3) and is used as the standard. 
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ESTIMATION OF SODIUM CONTENT OF PKC 
FLAME PHOTOMETRY 
Sodium (Na) is the major extracellular caution and it plays a role in body fluid 
distribution. Concentration of sodium ions inside the plasma (extracellular) is 130-145 m 
mo1/1. Higher and lower concentrations are referred to as hypernatremia and hyponatremia, 
respectively. 
When a solution containing cautions of sodium is spayed into flame, the solvent 
evaporates and ions are converted into atomic state. In the heat of the flame (temperature 
about 1800°C), small fraction of the atom is excited. Relaxation of the excited atom to the 
lower energy level is accompanied by emission of light (photons) with characteristics 
wavelength (Na:589 nm, K:766nm).Intensity of the emitted light depends on the 
concentration of particular atoms in flame. 
DETERMINATION OF PESTICIDE RESIDUES  
(Chlorpyriphos, DDT, Endosulfan, Malathion and Parathion) 
Determination of Pesticide residues: 
Pesticides are simple substances or mixtures used to eliminate undesirable vegetable 
and animal life in agricultural and urban ecosystems. Owing to the great varaiblity in plant 
chemical composition that results from factors to which plants are exposed during their 
growth, storage and the different stages of manipulation, characterization and standardization 
of phytopharmaceuticals are necessary. Medicinal plant materials are liable to contain 
pesticides residues, which accumulate from agricultural practices, such as spraying, treatment 
of soil during cultivation and administration of fumigants during storage. Pest control is used 
for the production of growing plants, plant products in warehouses. 
Pesticides can be classified according to their chemical composition, function and more 
of action in organisms. Chemically the compounds can be derived into three groups; Biological, 
inorganic and Organic Pesticide. Mainly the organochlorine, organophosphorues, carbonate and 
triazine compounds which is the largest and has pronounced physiological activity. Therefore it is 
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necessary of performing the determination of pesticides in accordance with the procedure 
outlined by national/international agencies. 
Pesticides are the only toxic substances released intentionally into our environment to 
kill living things. This includes substances that kill weeds (herbicides), insects (insecticides), 
fungus (fungicides), rodents (rodenticides), and others. Pesticides can cause many types of cancer 
in humans. Some of the most prevalent forms include leukemia, non-Hodgkins lymphoma, brain, 
bone, breast, ovarian, prostate, testicular and liver cancers. Acute dangers - such as nerve, skin, and 
eye irritation and damage, headaches, dizziness, nausea, fatigue, and systemic poisoning - can 
sometimes be dramatic, and even occasionally fatal. 
Table 7.9 Pesticides with acceptance limit 
S.No. Substance Limit (ppm) 
1 Alachlor 0.02 
2 Aldrin and dieldrin (sum of) 0.05 
3 Anilphos 0.1 
4 Atrazine 0.1 
5 Azinphos – methyl 1.0 
6 Bromopropylate 3.0 
7 Chlordane (sum of cis-, trans – and Oxythlordane) 0.05 
8 Chlorfenvinphos 0.5 
9 Chlorpyrifos 0.2 
10 Chlorpyrifos – methyl 0.1 
11 Cypermethrin (and isomers) 1.0 
12 DDT (sum of p,p’ – DDT, o,p’-DTT, p,p’-DDE, and p,p’-TDE 1.0 
13 Deltamethrin 0.5 
14 Diazinon 0.5 
15 2,4-Dichlorophenoxy acetic acid 0.5 
16 Dichlorvos 0.05 
17 Dithiocarbamates (as CS2) 1.0 
18 Endosulfan (sum of isomers and Endosulfan sulphate) 3.0 
19 Endrin 0.05 
20 Ethion 2.0 
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21 Fenitrothion 0.5 
22 Fenvalerate 1.5 
23 Fonofos  0.05 
24 Heptachlor (sum of Heptachlor and Heptachlorepoxide) 0.05 
25 Hexachloro Hexacyclohexane isomers 0.1 
26 Hexachlro Hexacyclohexane isomers 0.3 
27 Isoproturon 0.05 
28 Lindane (α-Hexachlorocyclohexane) 0.6 
29 Malathion 1.0 
30 Methidation 0.2 
31 Metoxuron 0.05 
32 Metribuzin 5.0 
33 Parathion 0.5 
34 Parathion – methyl 0.2 
35 Permethin 1.0 
36 Phosalone 1.0 
37 Piperonyl butoxide 3.0 
38 Pirimiphos – methyl 4.0 
39 Profenophos 0.05 
40 Pyrethrins (sum of) 3.0 
41 Quinalphos 0.05 
42 Quintozene (sum of qintozene, pentachloroaniline and methyl 
pentachlorophenyl sulphide) 
1.0 
 
Procedure: 
Note:  
 Reagents : All reagents and solvents are free from any contaminates, especially 
pesticides, which might interfere with the analysis. It is often necessary to use 
special quality solvents or if this not possible, solvents that have recently been re-
distilled in an apparatus made entirely of glass. In any case, suitable blank tests 
have been carried out. 
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 Apparatus: Cleaned the apparatus and especially glassware to ensure that they are 
free from pesticides, for example, soaked for at least 16 hours in a solution of 
phosphate-free detergent, rinsed with large quantities of distilled water and washed 
with acetone and hexane or heptane. 
 Kept the samples (before analysis) at a temperature below 0oC,  protected from 
light. 
DETERMINATION OF ORGANOCHLORINE, 
ORGANOPHOSPHORUS AND PYRETHROID INSECTICIDES 
(by size exclusion chromatography): 
Extraction (Solution A): 
Instrument : Rotary evaporator. 
Reagents: Acetone HPLC grade (distilled), Carbophenothion, Toluene HPCL grade 
(distilled). 
Procedure: 
1. To 10 g of the test sample 100 ml of acetone was added and allow to stand for 20 minutes. 
2. 0.200 ml of a solution containing 50 µg/ml of carbophenothion in toluene was added to it. 
3. Homogenized using a high-speed blender for 3 minutes. Filtered and washed the filter cake 
with two quantities, each of 25 ml, of acetone. 
4. Combined the filtrate and the washings and heated using a rotary evaporator at a 
temperature not exceeding 40°C until the solvent had almost completely evaporated. 
5. To the residue added a few ml of toluene and heated again until the acetone is completely 
removed. 
6. Dissolved the residue in 8 ml of toluene. Filtered through a membrane filter (45 µm), 
rinsed the flask and the filter with toluene and diluted to 10 ml with the same solvent 
(solution A). 
Purification: 
Instrument: Size exclusion chromatography with accessories as mentioned under 
chromatographic system. 
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Reagents: Methyl red, Oracet blue 2R, Toluene HPLC grade (distilled). 
Preparation of reagents: 
0.5 g/L solution of methyl red in toluene: 
Dissolved 50 mg of Methyl red in sufficient toluene to produce 100 ml. 0.5 g/L solution of oracet 
blue 2R in toluene: 
0.5 g/L solution of oracet blue 2R in toluene: 
Dissolved 50 mg of oracet blue 2R in sufficient toluene to produce 100 ml. Chromatographic 
system: 
Chromatographic system: 
Column : A stainless steel column 0.30 m long and 7.8 mm in internal diameter packed with 
styrene-divinylbenzene copolymer (5 µm) (TSK GEL-SCX).  
Flow rate: 1.5 mL/min. 
 Mobile phase: Toluene. 
Performance of the column: 
1. Injected 100 µl of a solution containing 0.5 g/L of methyl red and 0.5 g/L of oracet blue 
2R in toluene and preceded with the chromatography. 
2. The column is not considered suitable unless the colour of the eluate changes from orange 
to blue at an elution volume of about 10.3 ml. 
3. If necessary calibrated the column, using a solution containing, in toluene, at a suitable 
concentration, the insecticide to be analysed with the lowest molecular mass (for 
example, dichlorvos) and that with the highest molecular mass (for example, 
deltamethrin). Determined which fraction of the eluate contained both pesticides.  
Purification of the test solution (solution B): 
1. Injected a suitable volume of solution A (100 µl to 500 µl) and proceeded 
with the chromatography. 
2. Collected the fraction as determined above (solution B). 
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Organochlorine and pyrethroid insecticides: 
1. In a chromatography column, 0.10 m long and 5 mm in internal diameter, introduced 
a piece of defatted cotton and 0.5 g of silica gel treated as follows: 
2. Heated silica gel for chromatography in an oven at 150°C for 4 hours. 
3. Allowed to cool and added drop wise a quantity of water corresponding to 1.5% of the 
weight of silica gel used; shaked vigorously until agglomerates have disappeared and 
continued shaking for 2 hours using a mechanical shaker. 
4. Conditioned the column using 1.5 ml of hexane. 
Note: Prepacked columns containing about 500 mg of a suitable silica gel was also 
used and they were previously validated. 
Solution C: 
1. Concentrated solution B in a current of helium or oxygen-free nitrogen almost to 
dryness and diluted to a suitable volume with toluene (200 ul to 1 ml according to the 
volume injected in the preparation of solution B). 
2. Transfered quantitatively onto the column and proceeded to the chromatography using 
1.8 ml of toluene as the mobile phase. Collected the eluate (solution C). 
Quantitative analysis: 
Organophosphorus insecticides (By GC):  
Instrument: 
Gas chromatograph with accessories as mentioned under chromatographic system. Reagents: 
Toluene Chromatographic system: 
Column: A fused-silica column 30 m long and 0.32 mm in internal diameter the internal wall 
of which is covered with a layer 0.25 um thick of poly (dimethyl) siloxane (DB-1). 
Carrier gas: Helium at flow rate of 0.9 ml / min. 
Test Solution: 
 Concentrated solution B in a current of helium almost to dryness and diluted to 50 to 
250 µl with toluene. 
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Standard stock solution A: 
 Weighed accurately about 5.0 mg of each of the standards as listed in the table in 
separate 10 ml volumetric flasks, dissolved in toluene and made up the volume with the same 
solvent, and mixed. 
Standard stock solution B: 
 Pipetted a volume of standard stock solution A (for each standard) and diluted to 
volume with toluene. 
Table 7.10 Standard stock solutions A and B for Organophosphorus isercticides 
S.No Substance 
Volume of 
standard stock 
solution A to 
be prepared 
(ml) 
Volume of 
standard 
stock 
solution B to 
be prepared 
(ml) 
Relative 
retention time 
with respect to 
carbophenothion 
1 Isoproturon 0.050 
10 
0.25 
2 Metoxuron 0.050 0.33 
3 Atrazine 0.100 0.57 
4 Fonofos 0.050 0.6 
5 Diazion 0.500 0.62 
6 Mtribuzin 5.000 0.66 
7 Methyl - Parathion 0.200 0.68 
8 Yrifos - Methyl 0.100 0.69 
9 Primiphos 4.000 10 0.73 
10 Fenitrothion 0.500 
10 
0.73 
11 Malathion 1.000 0.74 
12 Parathion 0.500 0.75 
13 Chlorpyrifos 0.200 0.76 
14 Quinalphos 0.050 0.82 
15 Methidathion 0.200 0.84 
16 Carbophenothion 0.300 10 1.00 
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17 Anilophos 0.100 1.11 
18 Azinophos methyl 1.000 1.13 
19 Phosalone 0.1000 1.14 
20 Ethion 2.000 0.97 
21 Chlorfenvinphos 1.500 1.10 
 
Reference solution – I: 
 Transfer 0.5 ml each of standard stock solution B into a 50 ml volumetric flask and 1 
ml of internal standard solution (Containing 50 µg/ml carbophenothion) and made up the 
volume with toluene, and mixed. 
Reference Solution – II: 
 Transfer 1 ml each of standard stock B into a 50 ml volumetric flask and 1 ml of 
internal standard solution (Containing 50 µg/ml carbophenotion) and made up the volume 
with toluene, and mixed. 
Reference solution-Ill: 
Transfer 1.5 ml each of standard stock solution B into a 50 ml volumetric flask and 1 ml of 
internal standard solution (Containing 50 µg/ml carbophenothion) and made up the volume 
with toluene, and mixed.  
Procedure: 
1. Injected the chosen volume of each of reference solution-I, reference solution-Il and 
reference solution-Ill, into chromatograph, recorded the chromatograms and ploted 
the calibration curve. 
2. When the chromatograms were recorded in the prescribed conditions, the relative 
retention times were approximately those listed in table 7.10. 
3. Injected the test solution, into chromatograph and recorded the chromatograms. 
4. Calculated the content of each of Organophosphorus insecticides from the peak areas 
and the concentrations of the solutions. 
 
 
MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 70 
 
Organochlorine and pyrethroid insecticides:Dithiocarbamates (by GC): 
Instrument: 
Gas chromatograph with a device allowing direct cold on- column injection. 
and other accessories as mentioned under chromatographic system. 
Reagents: Toluene. 
Chromatographic system: 
Column: A fused silica column 30 m long and 0.32 mm in internal diameter the internal 
wall of which is covered with a layer 0.25um thick of poly (dimethyl) (diphenyl) siloxane. 
Carrier gas: Helium at flow rate of 1.4 ml/min. 
Temperature: 
Column: 80°C for 1 minute, then raising it at a rate of 30°C/ minute to 150°C, maintaining 
at 150°C for 3 minutes, then raising the temperature at a rate of 4°C per minute to 280°C 
and maintaining at this temperature for 2 minute. 
Injection port: 250°C 
Detector: 275 °C 
Detection: An electron- capture detector.  
Test solution: 
Concentrated solution C in a current of helium or oxygen-free nitrogen almost to dryness and 
diluted to 50 to 250µl with Toluene. 
For Organochlorine and pyrethroid insecticides: 
Standard stock solution A: 
i. Weighed accurately about 5.0 mg of each of the standards as listed in the table in 
separated 10 ml volumetric flasks, dissolved in toluene and made up the volume with 
the same solvent, and mixed. 
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Standard stock solution B: 
1. Pipetted a volume of standard stock solution A (for each standard) and diluted to 
volume with toluene, as indicated in the table. 
Table 7.11 Standard stock solution A and B for Organochlorine and pyrethroid 
insecticides 
S.No. Substance 
Volume of 
standard stock 
solution A 
taken (mL) 
Volume of 
standard stock 
solution B to 
be prepared 
(mL) 
Relative 
retention time 
with respect to 
carbophenothion 
1 Dichlorvos 1.000 
10 
0.2 
2 alpha - HCH 0.300 0.48 
3 Hexachlorobenzen E 0.100 0.49 
4 
Dichlorophenoxy acetic 
acid 
0.050 0.52 
5 Beta - HCH 0.300 0.53 
6 Lindane 0.600 0.53 
7 Quintozene 1.000 0.54 
8 Pentachloroaniline 1.000 0.61 
9 Heptachlor 0.050 0.65 
10 Alachlor 0.200 
10 
0.66 
11 Aldrin 0.050 0.71 
12 Heptachlor Epoxide 0.050 0.78 
13 2,4-DDE 1.000 0.83 
14 Alpha-Exndosulfan 3.000 0.84 
15 Chlordane 0.050 0.82 
16 Dialdrin 0.050 0.88 
17 4,’4-DDE 1.000 
10 
0.88 
18 2,4-DDD 1.000 0.9 
19 Endrin 0.050 0.92 
20 Beta-Endosulfan 3.000 10 0.93 
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21 2,4-DDT 1.000 0.96 
22 Pyrethrins 3.000 0.91 
23 Carbophenothion  10 1 
24 4,4-DDT 1.000  1.02 
25 Bromopropylate 3.000  1.20 
26 Poperonyl Butoxide 3.000  1.21 
27 Permethrin 1.000 
10 
1.27 
28 Cypermethrin 1.000 1.27 
29 Fenavalerate 1.500 1.44 
30 Deltamethrin 0.500 1.5 
 
Reference solution – I: 
 Transfered 0.5ml each of standard stock solution B into a 50 ml volumetric flask, and 
1 ml of internal standard solution (Containing 50 µg/ml carbophenothion) and made up the 
volume with toluene, and mixed. 
Reference solution – II: 
 Transfer 1 ml each of standard stock solution B into a 50 ml volumetic flask and 1 ml 
of internal standard solution (Containing 50 µl/mg carbophenothion) and made up the volume 
with toluene, and mixed. 
Reference solution – III: 
 Transfer 1.5ml each of standard stock solution B into a 50 ml volumetric flask and 1 
ml of internal standard solution (Containing 50 µg/ml carbophenothion) and made up the 
volume with toluene, and mixed. 
Procedure: 
1. Injected the chosen volume of reference solution-I, reference solution-II and reference 
solution-III, into chromatograph, recorded the chromatograms and ploted the 
calibration curve. 
2. When the chromatograms were recorded in the prescribed conditions, the relative 
retention times were approximately those listed in table  - 7.11. 
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3. Injected the test solution, into chromatograph and recorded the chromatograms. 
4. Calculated the contest of Organochlorine and pyrethroid insecticides, from the peak 
areas and the concentrations of the solutions. 
For dithiocarbamates insecticides: 
Standard stock solution A: 
 Weighed accurately about 5.0 mg of each of the standards as listed in the table in 
separate 10 ml volumetric flasks, dissolved in toluene and made up the volume with the same 
solvent, and mixed. 
Standard stock solution B: 
 Pipetted a volume of standard stock solution A (for each standard) and diluted to 
volume with toluene as indicated in the table. 
Table 7.12 Standard stock solution A and B for carbophenothion 
S.No. Substance 
Volume of 
Standard stock 
solution A 
taken (ml) 
Volume of 
standard stock 
solution B to 
be prepared 
(ml) 
Relative 
retention time 
with respect to 
carbophenothion 
1 Dithiocarbamates 2.000 10 1.10 
 
Reference solution – I: 
 Transfered 0.5 ml each of standard stock solution B into a 50 ml volumetric flask and 
1 ml of internal standard solution (Containing 50 µg/ml carbophenothion) and  made up the 
volume with toluene and mixed. 
Reference solution – II:  
 Tranfered 1 ml each of standard stock solution B into a 50 ml volumetric flask and 1 
ml of internal standard solution (Containing 50 µg/ml carbophenothion) and made up the 
volume with toluene and mixed. 
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Reference solution – III: 
Tranfered 1.5 ml each of standard stock solution B into a 50 ml volumetric flask and 1 ml of 
internal standard solution (Containing 50 µg/ml carbophenothion) and made up the volume 
with toluene and mixed. 
Procedure: 
1. Injected the chosen volume of each of reference solution – I, reference solution – II 
and reference solution – III, into chromatopraph, record the chromatograms and 
ploted the calibration curve. 
2. When the chromatograms were recorded in the prescribed conditions, the relavtive 
retention times were approximately those listed in Table 7.12. 
3. Injected the test solution, into chromatograph and recorded the chromatograms. 
4. Calculated the content of dithiocarbamates insecticides, from the peak areas and the 
concentrations of the solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 75 
 
TEST FOR AFLATOXINS 
 Aflatoxins are highly dangerous and extreme care should be exercise in handling 
aflatoxin materials. 
 This test is provided to detect the possible presence of aflatoxins B1, B2, G1 and G2 in 
any material of plant origin.  
Method – ELISA Method 
Aflatoxin solution 
 Dissolve accurately weighted qauantities of aflation B1, Aflatoxin solution B2, 
aflatoxin G1 and aflatoxin G2 in a mixture of chloroform and acetonitrile (9.8:0.2) to and 
obtain a solution having concentration of 0.5 µg/per ml each for aflatoxin B1 and G1and 0.1 
µg per ml each for aflatoxins for B2 and G2. 
Total Aflatoxin Content:  
 About 2 ±0.0001 g of a disintegrated sample was weighted and extracted with 10 ml 
of methanol – water mixture (7 + 3) to separate aflatoxin. To that end, the rest was 
homogenised for 10 min at room temperature and then the resultant deposit was centrifuged. 
An aliquot (100 µl) of the supernatant was diluted with 600 µl of phosphate buffer at pH=7.2. 
An alquot of this solution (50 µl) or standard solution (50 µl), 50 µl of the aflatoxin – 
peroxidise conjugate and 50µl of the mouse antibody solution against alfatoxin were added to 
each well of the used plate. The determination was repeated three times. The samples were 
incubated for 30 min at room temperature in the darkness. The free and peroxidise – 
combined aflatoxins compete for the combining site with antibodies to mouse antibodies 
immobilised on the plate. Next, the plate was emptied and washed five times with phosphate 
buffer pH =7.2. Then, 50µl of tetramethylbrnzidine and 50 µl of urea peroxide were added 
and incubated again for 30 min in darkness. The reaction was terminated by added 100µl of 
the stop reagent. The absorbance of solution was measured at a wavelength of 450 nm, using 
ELISA reading apparatus. The content of aflatoxins was using the previously prepared 
standard curve. 
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7.5 PHYTOCHEMICAL STANDARDIZATION
6,7,115
  
 The nature of phytoconstituents present in the plant is determined by phytochemical 
studies by using suitable chemical tests. The physiological function in the human body is 
mainly determined by the presence of primary and secondary metabolites obtained from 
plants. So, pharmacology is mostly recognized by the nature of therapeutic phytoconstituents. 
It can be done by confirmation with different chromatographic techniques like TLC and 
HPTLC. Therefore a complete investigation is required to characterize the phytoconstituents 
qualitatively and quantitatively. 
Methods 
 The raw materials were authenticated and shade dried for few days which is then 
powdered and stored in a well closed container. 
Preparation of Extracts 
 The ethanolic solvent extract separately prepared by adding 30 gm herbal preparation 
(powder) in 300 ml of ethanol solvent in screw-capped bottles, shacked at 190-220 rpm on a 
rotary shaker. After 24 h of shaking, it was filtered, evaporated in vacuum and dried by rotary 
evaporator at 60°C. Dried extract were stored in labelled sterile screw capped bottles at 4°C 
and later used in further study. 
As per Ayurvedic Pharmacopoeia of India, the following parameters have 
been tested for PKC 
 Qualitative phytochemical screening 
 Quantitative Phytochemical estimation 
 TLC studies 
 HPTLC fingerprinting with bio-marker 
 GC-MS analysis 
QUALITATIVE PHYTOCHEMICAL SCREENING 
 The different qualitative chemical tests were performed for establishing profile of 
PKC extract for its chemical composition. The tests were performed extracts to detect 
various phytoconsituents present in them. 
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Detection of Alkaloids 
 50 mg of the sample was stirred with few ml of dilute hydrochloric acid and filtered. 
The filtrate is tested carefully with various alkaloidal reagents as follows 
Mayer’s test 
 To few ml of filtrate, 1-2 drop of Mayer’s reagent (Potassium mercuric iodide 
solution) was added by the sides of the test tube. A white or creamy precipitate indicates the 
test as positive. 
Wagner’s test 
 To a few ml of filtrate, few drops of Wagner’s reagent (Iodine potassium iodide 
solution) was added by the side of the test tube. A reddish – brown precipitate confirms the 
test as positive. 
Hager’s test 
To a few ml of filtrate, 1 or 2 ml of Hager's reagent (saturated solutions of picric acid) 
was added. A prominent yellow precipitate indicates the test as positive 
Dragendorff’s test 
To a few ml of filtrate, 1 or 2 ml of Dragendorff’s reagent (Potassium bismuth iodide 
solution) were added. A reddish brown indicates the test as positive. 
Detection of Carbohydrates and Glycosides 
The extract (100 mg) is dissolved in 5 ml of distilled water and filtered. The filtrate is 
subjected to the following tests.  
Molish's test 
To 2 ml of filtrate, two drops of alcoholic solution of a-naphthol were added, the 
mixture was shaken well and 1 ml of concentrated sulphuric acid was added slowly along the 
sides of the test tube and allowed to stand. A violet ring indicates the presence of 
carbohydrates. 
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Fehling's test 
One ml of filtrate was boiled on water bath with 1 ml each of Fehling solutions A and 
B. A red precipitate indicates the presence of sugar.  
Barfoed's test 
To 1 ml of filtrate, 1 ml of Barfoed's reagent was added and heated on a boiling water 
bath for 2 minute. Red precipitate indicates presence of sugar.  
Benedict's test 
To 0.5 ml of filtrate, 0.5 ml of Benedict's reagent was added. The mixture was heated 
ona boiling water bath for 2 minute. A characteristic coloured precipitate indicates the 
presence of sugar.  
For detection of glycosides 
50 mg of extract was hydrolysed with concentrated hydrochloric acid for 2 hour on a 
water bath, filtered and the hydrolysate was subjected to the following tests. 
Borntrager's test 
To 2 ml of filtered hydrolysate, 3 ml of chloroform was added and shaken, 
Chloroform layer was separated and 10% ammonia solution was added to it. Pink colour 
indicates the presence of glycosides. 
Legal's test 
Fifty mg of extract was dissolved in pyridine; sodium nitroprusside solution was 
added and made alkaline using 10% sodium hydroxide. Presence of glycoside was indicated by 
pink colour.  
Detection of Saponins 
The extract (50 mg) was diluted with distilled water and made up to 20 ml. The 
suspension was shaken in a graduated cylinder for 15 minutes. A two cm layer of foam 
indicates the presence of saponins.  
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Detection of Proteins and Amino acids 
The extract (100 mg) was dissolved in 10 ml of distilled water and filtered through 
whatmann No. 1 filter paper and the filtrate was subjected to tests for proteins and amino acids. 
Million’s test 
To 2 ml of filtrate, few drops of Millon's reagent was added. A white precipitate 
indicates the presence of proteins. 
Biuret test 
An aliquot of 2 ml of filtrate was treated with one drop of 2% Copper sulphate 
solution. To this, 1 ml of ethanol (95%) was added, followed by excess of potassium 
hydroxide pellets. Pink colour in the ethanolic layer indicates the presence of proteins.  
Ninhydrin test 
Two drops of ninhydrin solution (10 mg of ninhydrin in 200 ml of acetone) were 
added to 2 ml of aqueous filtrate. A characteristic purple colour indicates the presence of 
amino acids. 
Detection of Phytosterols 
 Libermann-Burchard's test 
The extract (50 mg) was dissolved in 2 ml acetic anhydride. To this, 1-2 drops of 
concentated sulphuric acid were added slowly along the sides of the test tube. An array of 
colour changes shows the presence of phytosterols. 
Detection of Fixed Oils and Fats 
Spot test 
A small quantity of extract was pressed between two filter papers. Oil stain on the 
paper indicates the presence of fixed oil.  
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Saponification test 
A few drops of 0.5 N alcoholic potassium hydroxide solution were added to a small 
quantity of extract along with a drop of phenolphthalein. The mixture was heated on water 
bath for 2 hour. Formation of soap or partial neutralisation of alkali indicates the presence of 
fixed oils and fats. 
Detection of Phenolic compounds and Tannins  
Ferric chloride test 
The extract (50 mg) was dissolved in 5 ml of distilled water. To this, few drops of 
neutral 5% ferric chloride solution were added. A dark green colour indicates the presence of 
phenolic compounds.  
Gelatine test 
The extract (50 mg) was dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
gelatine containing 10% sodium chloride was added to it. White precipitate indicates the 
presence of phenolic compounds.  
Alkaline reagent test 
An aqueous solution of the extract was treated with 10% ammonium hydroxide 
solution. Yellow fluorescence indicates the presence of flavonoids.  
Lead acetate test 
The extract (50 mg) was dissolved in 5 ml of distilled water and to this, 3 ml of 10% 
lead acetate solution was added. A bulky white precipitate indicates the presence of phenolic 
compounds.  
Magnesium and hydrochloric acid reduction  
The extract (50 mg) was dissolved in 5 ml of alcohol and few fragments of 
magnesium ribbon and concentrated hydrochloric acid (drop wise) are added. If any pink to 
crimson colour develops, presence of flavanol glycosides was inferred. 
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Detection of Gum and Mucilages 
The extract (100 mg) was dissolved in 10 ml of distilled water and to this. 25 ml of 
absolute alcohol was added with constant stirring. White or cloudy precipitate indicates the 
presence of gums and mucilages.  
Detection of Volatile Oil 
In a volatile oil estimation apparatus, 50 gram of powdered material (crude drug) was 
taken and subjected to hydro-distillation. The distillate was collected in graduated tube of the 
assembly, where in the aqueous portion automatically separated out from the volatile. 
QUANTITATIVE PHYTOCHEMICAL ESTIMATION 
Determination of Total flavonoid Content 
 Total flavonoid content was measured by the aluminum chloride colorimetric assay. An 
aliquot (1ml) of extracts or standard solutions of quercetin (20,40,60,80 and 100 µg/ml) was added 
to 10 ml volumetric flask containing 4 ml of distilled water. To the flask 0.30 ml of 5% NaNO2 was 
added and after 5 min 0.3 ml of 10% AlCl3 was added. After 5 min, 2 ml of 1M NaOH was added 
and the volume was made up to 10 ml with distilled water. That solution was mixed and absorbance 
was measured against the blank at 510 nm. The total flavonid content was expressed as mg 
quercetin equivalents (QE).  
7.6 PHYTO-ANALYTICAL STANDARDIZATION 
THIN LAYER CHROMATOGRAPHY (TLC) ANALYSIS
6-7,49,90,104,115, 
The term chromatography (Greek Kromatos-colour and Graphos-written) meaning colour 
writing. Chromatography represents a group of methods for separating molecular mixtures that 
depend on the differential affinities of the solute between two immiscible phases. IUPAC has 
defined chromatography as "A method used primarily for the separation of the components of 
a sample, in which the components are distributed between two phases, one of which is 
stationary while the other moves. The stationary phase may be a solid or a liquid supported 
on a solid or a gel, and may be packed in a column, spread as a layer or distributed as a film. 
The mobile phase may be gaseous or liquid". 
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In TLC, the separation is carried on a glass or plastic plate, which is coated with a thin 
uniform layer of finely divided inert adsorbent such as silica gel or alumina. The special 
advantages of TLC compared to PC (Paper chromatography) include versatility (a number of 
different adsorbents besides cellulose may be used), greater speed (due to more compact 
nature : of the adsorbent when spread on a plate) and sensitivity (separations on less than ug 
amounts of materials can be achieved). One more advantage over PC is that glass plates may 
be spread withcone. H2SO4, a useful detection reagent for steroids and lipids. One of the 
original disadvantagesof TLC was the labour of spreading glass plates with adsorbent, a 
labour somewhat eased by theautomatic spreading devices. 
Procedure 
The glass plates were carefully cleaned with acetone to remove grease. Then the slurry of 
silica gel (or other adsorbent) in water was vigorously shaken for a set time interval before 
spreading. Finally, plates after spreading have been air dried and then activated by heating in 
anoven at 100-110
o
C for 30 minutes. The solution of the sample in a volatile solvent was 
applied I using a capillary tube or a micropipette to a spot keeping 1.2 cm from the bottom of 
the TLC late. The position of the sample spot was indicated by making a 'origin line' on the 
plate with the lead pencil. The spot was dried, the plate was placed vertically in a suitable 
tank (which is paper-lined so that the atmosphere inside is saturated with the solvent phase) 
with its lower edge immersed in selected mobile phases. The solvent raised by capillary action, 
resolving the sample mixture into discrete spots. 
Adsorbent: Silica gel 60 F254 
Solvent system: 
Toluene: Ethyl acetate: Diethylamine (5:3:2) for Alkaloids 
Toluene: Chloroform: Acetone (3:5:2) for Flavonoids 
Chloroform: Glacial acetic acid: Methanol: Water (64:32:12:8) for Saponins 
Diethyl ether: Toluene (1:1; Saturated with 10 % acetic acid) for Coumarins 
Toluene: Ethyl acetate (93:7) for Essential oils 
Ethyl acetate: Methanol: Water (100:13.5:10) for Glycosides 
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Benzene: Ethyl acetate: GAA (7:1:5:1:5) for Steroids 
Benzene: Methanol: Acetic acid (5:4:1) for Tanins and Phenols  
n-Butanol: Acetic acid: water (2:1:7) for Amino acids and Proteins 
Detection: The developed chromatogram was first inspected under UV light. After 
preliminary inspection in UV light, each chromatogram was analyzed for the presence of 
drug constituents by spraying with an appropriate group reaaent. 
Rf value 
The Rf value is the distance of a compound moves in chromatography relative to the solvent 
front. It is calculated by using the formula 
Rf =           Distance travelled by component from base line  
Distance travelled by the solvent front from the base line 
 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
(HPTLC)
6-8,115
 
 HPTLC is the most simple separation technique today available to the analyst. It can 
be considered a time machine that can speed our work and allows us to do many things at a 
time usually not possible with other analytical techniques. 
 For Scanning of UV/Visible/Fluorescence scanner scans the entire chromatogram 
qualitatively and quantitatively and the scanner is an advanced type of densitometer.  
Steps involved in HPTLC 
1. Selection of chromatographic layer 
2. Sample and standard preparation 
3. Layer pre-washing 
4. Layer pre-conditioning 
5. Application of sample and standard 
6. Chromatographic development 
7. Detection of spots 
8. Scanning 
9. Documentation of chromatic plate 
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Development of HPTLC finger print 
 The sample were applied at a concentration of 2-12 µl and standard at about 10µl 
were applied using CAMAG Linomate V sample applied on aluminium sheets precoated with 
silicagel 60F254 (Merck) 0f 0.2mm layer thickness and 20x10 cam will be used as a 
stationary phase in different track. 
 The plant was development in the mobile phase to distance of 70mm for developing 
the chromatogram. The developments were carried out in CAMAG twin through glass 
chamber. 
 Maintain the band width as 8m and applied the band on the plant at a distance of 
12mm. The different tracks were scanned using CAMAG densitometer scanner 3VI. 13 
equipped with CATS V 4.04 software at a wavelength of 254 and 366 nm using deuterium 
lamp and recorded the finger print profile. 
Reagents: 
 Toluene KF (Karl Fischer) grade 
 Ethyl acetate Rankem grade 
 Formic acid KF grade 
 Methanol Finar grade 
Mobile Phase: 
Quercetin with Formulation of PKC 
 Prepared a mixture of Toluene : Ethyl acetate : Formic acid (6: 4: 1) 
Formulation of PKC with Individual Plant Extract  
 Prepared a mixture of Toluene : Ethyl acetate : Formic acid : Methanol (12: 9: 4: 0.5) 
Santalum album with Formulation PKC 
 Prepared a mixture of Toluene : Ethyl acetate (9.3: 0.7) 
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Test Solution: 
1. Weighed accurately about 2.5 g of dried and powdered test sample. 
2. Added 50 ml of methanol and sonicated for 15 minutes with slight warming. 
3. Cooled the solution and filtered through a Whatman filter paper No.1. 
Procedure: 
Development chamber: 
 Took clean, dried twin trough HPTLC development chamber. Put a piece of filter 
paper (camag saturated pad) into one trough of the development chamber. 
Application of spots: 
1. Taken, pre-coated Aluminium HPTLC plate (coated with 0.25 mm layer of 
chromatographic silica gel 60 F254) 10 cm of height and applied 2 -12 µl each of the 
filtered test solution and reference solution 10 µl on the plate at a height of about 12 
mm distance from the base of the plate with the help of applicator. 
2. Allowed the sport to dry in air. 
Saturation of development chamber and HPTLC plate: 
1. Tranfered mobile phase through the filter paper through of development chamber. 
2. Placed plate into other trough (without mobile phase) of development chamber. 
3. Closed the chamber with chamber lid and saturated the chamber as well as plate with 
mobile phase for 30 minutes. 
4. After 30 minutes, opened the chamber lid took out the saturated plate and tiled the 
development chamber such that there is equal distribution of mobile phase in both 
troughs of development chamber. 
Development: 
 Placed the saturated plate into same trough (now filled with mobile phase) and 
developed using the mobile phase until the solvent front had moved up to 8 cm to 9 cm from 
application position. 
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Scanning: 
1. Took out the plate from development chamber. 
2. Marked the solvent front at one corner with a pencil, dried the plate in air and scanned 
the plate using TLC Scanner at 254 & 366 nm. 
Photograph: 
 Taken the photograph of the scanning plate with the help of digital camera and tested 
under UV light at 366 nm. 
Acceptance criteria: 
The Rf of main peaks obtained with the test solution from Rf 0.1 onwards correspond to those 
obtained with the reference solution after scanning at 254 & 366 nm. 
GC-MS ANALYSIS OF PKC 
 The in-house prepared formulation of PKC was extracted with ethanol and analyzed 
through GC-MS for identification of different compounds. 
 GC-MS analysis was carried out using Perkin Elmer GC Clarus 500. It consists of an 
automatic operation controller (AOC-20i auto injector) and Gas Chromatograph Interfaced to 
a Mass Spectrometer. Elite - 5 MS (5% diphenyl 95% dimethyl poly siloxane) capillary 
column (30 x 0.25mm x 0.25µm df) employing for separation of components and operating 
in mass detector turbo mass gold mode at 70eV. Helium was used  as carrier gas at a constant 
flow of 1ml/min and an injection volume of 2µl was employed. The temperature of Injector 
and ion source were maintained at 270
o
C and 200
o
C respectively. The oven temperature was 
programmed from 50
o
C for 2 min, inversed to 150
o
C at 8
o
C/min and to 240
o
C at 8
o
C/min, 
and held at 270°C for 20 min. Mass spectra were obtained at 70eV. A scan interval is 0.5 
seconds and fragments from 40-450 Da. The amount of each component was calculated and 
relative percentage basis comparing its average pack area to the total areas. The total Ion 
chromatogram was created by summing up intensities of all mass spectral peaks. The TIC 
was compared with GC chromatogram. Turbo Mass Version 5.2.0 Software was adopted to 
handle mass spectra and chromatograms. 
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Identification of compounds 
 The Compounds were identified by interpretation of the spectrum of the unknown 
compounds with the spectrum of the known compounds mentioned in The Vellore Institute of 
Technology University (VIT) library database. 
7.7 PHARMACOLOGICAL SCREENING  
IN-VITRO SKIN DISEASES ACTIVITY OF PKCF
53,94
 
Anti-Bacterial and Anti- Fungal activity of PKCF
17-18,54,76,87,101,106
 
Preparation of Extracts 
 The ethanolic solvent extract separately prepared by adding 30 gm herbal preparation 
(powder) in 300 ml of ethanol solvent in screw-capped bottles, shacked at 190-220 rpm on a 
rotary shaker. After 24 h of shaking, it was filtered, evaporated in vacuum and dried by rotary 
evaporator at 60°C. Dried extract were stored in labelled sterile screw capped bottles at 4°C 
and later used in in-vitro study. 
Microbial Strains 
Two strains of bacteria and one strains of fungi were procured from the Microbial 
Type Culture Collection (MTCC) apex manufacturing company, kunnam, Chennai, and were 
tested: Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae, Pseudomonas aeruginosa 
(Gram-negative) and Fungai Candida albicans. All the strains were stored at freeze 
temperature until use. 
Culture media 
Anti-Bacterial Assay 
This was done to evaluate in-vitro activity of the antibacterial agents. The results were 
reported quantitatively in terms of diameter of zones of inhibition. Nutrient agar was used for 
sub culturing of the test micro-organisms at 37°C for 24 hours and Mueller Hinton agar was 
used for sensitivity assay. The Media was reconstituted according to the Manufacturers 
instruction, sterilized by autoclaving at 121°C for 15 minutes and then dispensed aseptically 
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into Petri dishes (9 cm diameter) in a volume of 22 millilitres molten agar and left to solidify 
and then stored in the refrigerator at 4°C. 
Disc Diffusion Test for Anti Bacterial Activity 
 The anti-microbial activity was assayed by disc diffusion method. The bacterial 
strains were activated by growing them in Nutrient agar at 37°C for 18 – 24 hours. 
Freshinoculum was developed by suspending activated colonies in physiological saline 
solution (0.85% NaCl). The cell suspension was then standardized using 0.5 McFarland 
turbidity standards. The suspension was used to aseptically inoculate by swabbing the surface 
of Mueller Hinton agar plates. The impregnated discs with different concentration of extracts 
were then planted at equidistant points on top of the inoculated agar medium by sterile 
forceps. The positive control  disc was also planted. The inoculated plantes were then 
incubated at 4°C for 2 hours to allow prediffusion of extracts into the media then incubated at 
37°C for 24 hours after which they were inspected of zones of inhibition. Anti bacterial 
activity was then evaluated by measuring the diameter of the inhibition zones. Experiment 
was carried out in triplicate and the average diameter of zone of inhibition was recorded. The 
antibacterial activity was classified as highly active (>20mm), mild active (15-20mm) and 
slightly active (12-15mm) and less then 12mm was taken as inactive. Results were expressed 
as mean ± standard deviation.  The Minimum Inhibitory Concentration were also observed 
for the churnam extracts. 
Anti-Fungal Assay
75,78,109
 
Preparation of inoculums 
Bacterial inoculums were prepared by growing freeze-dried cells in NA for 24 h at 
37 °C. Slants were prepared by streaking of these cell suspensions and sub culturing was 
done by using the same broth to provide initial cell counts of about 10
4
 CFU/ml and 
incubated at 37 °C for required time. The filamentous fungi were grown on SDA slants at 
25 °C for seven days and the spores were collected using sterile double distilled water and 
homogenized. 
Well diffusion method assay 
Petri plates were prepared by pouring 30 ml of SDA medium for the fungai. The test 
organism was inoculated on solidified agar plate with the help of micropipette and spread and 
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allowed to dry for 10 min. The wells or cavities were made in agar containing each petri dish 
by a sterilized steel borer. To these cavities standard and test compound solutions were filled. 
All the works were carried out under aseptic conditions for microbial assay. The plates for the 
fungai incubated at 37 °C ± 1°C for 24 h. The fungal strain C. albicans incubated at 25 °C for 
72 h and seven days, respectively. All the samples will tested in triplicate. The antifungal 
potential of test strains and the control activity was determined on the basis of zone of 
inhibition around the wells in millimetres. Results were expressed as mean ± standard 
deviation. The Minimum Inhibitory Concentration were also observed for the churnam 
extracts. 
Preparation of Discs for Anti-bacterial and Anti-fungal activity 
Whatmann filter (No.1) discs of 6mm diameter were made by punching the paper and 
the blank discs were sterilized in hot air oven at 160°C for one hour. They were then 
impregnated with 10 µl of the varying concentration of the PK churna crude extract solution. 
The impregnated discs were thenevaproted at 50°C till they dried. Gentamycin 10 µg/disc, 
Ciproflaxacia 5µg/disc, Amikacin 30µg/disc, Piperacillin/ Tazobactam 100 µg/10 µg/disc, 
Doxycycline 30µg/disc, Flucanazole 20µl/disc, Terbinafile 20µl/disc was used as a positive 
control due to its broad spectrum property. 
Preparation of test sample 
The ethanol extract dissolved in 10% aqueous DMSO to obtain different 
concentrations (313 µg, 625 µg, 1250µg, 2500µg, 5000µg). Negative controls used were 10% 
aqueous DMSO (solvent control). Gentamycin 10 µg/disc, Ciproflaxacia 5µg/disc, Amikacin 
30µg/disc, Piperacillin/ Tazobactam 100 µg/10 µg/disc, Doxycycline 30µg/disc, Flucanazole 
20µl/disc, Terbinafile 20µl/disc were used as positive reference standards having a different 
concentration for all bacterial and fungal strains. 
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8. RESULTS AND DISCUSSION 
MORPHOLOGY STUDIES 
 The crude drugs used in the formulation are viewed macroscopically through the 
naked eyes and the results are tabulated as follows: 
Table 8.1 Results of Macroscopical Studies 
S.
NO 
PLANT 
NAME 
COLOUR ODOUR TASTE 
SURFACE 
CHARACTERIS
TICS 
SIZE AND 
SHAPE 
1 
Trichosanthes 
dioica Roxb 
Upper 
surface 
green, 
lower 
surface 
dull green 
Not 
specific 
Slightly 
bitter 
Both surfaces are 
very rough with 
rigid hairs. 
Sinuate and 
dentate margin, 
cordate base,    
acute to 
acuminate apex. 
Ovate-oblong 
Cordate 
2 
Picrorhiza 
kurroa Royle 
ex Benth 
Greyish 
brown 
Pleasant 
 
Extremely 
bitter 
Rough due 
towrinkles, 
circular scales of 
roots, marked 
with numerous 
partially 
encircling closely 
arranged scaly 
leaves or scars of 
leaves, attached 
with a few roots 
fracture short. 
Rhizome about 
5.4 cm in 
length and 6.3 
mm in width. 
3 
Santalum 
album Linn 
Reddish 
brown 
Highly 
fragment 
Bitter 
Straight grains 
and splits easily 
longitudinally, 
Log and chips 
varying in 
width and 
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heavy and solid. length. 
4. 
Marsdena 
tenacissima 
Yellow to 
buff 
coloured 
with dark 
brown 
patches 
Indistinct 
Slightly 
bitter 
Longitudinally 
ridges and 
furrow 
present.Fracture,
fibrous in 
wood,granular in 
bark region and 
short. 
Cylindrical,0.6 
to 2.6 cm thick 
and varying in 
length. 
5. 
Tinospora 
cordifolia 
(Wild.Miers.) 
Dark 
brown 
Odourless Bitter 
Wood light in 
weight,bark 
warty,numerous 
lenticels,perforat
ed,dried sample 
conical 
pieces,bark 
papery,longitudin
al ridges,difficult 
to fracture 
Varying in 
length. 
6. 
Cissampelos 
pareira Linn. 
Yellowish 
grey 
Aromatic 
At first 
sweetish 
and 
aromatic, 
latter 
slightly 
bitter. 
Cylindrical 
tortuous 
pieces,entire or 
split 
longitudinally,lon
gitudinally 
wrinkled,woody 
internally. 
1 to 4 cm in 
diameter,10 cm 
to 1.0 m long. 
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Fig 8.1 Morphology of Trichosanthes dioica Roxb 
 
 
 
 
 
 
 
 
 
Fig 8.2 Morphology of Picrorhiza kurroa Royle ex Benth 
RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 93 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 8.3 Morphology of Santalum album Linn 
 
 
 
 
 
 
 
 
 
 
Fig 8.4 Morphology of Marsdena tenacissima 
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Fig 8.5 Morphology of Tinospora cordifolia (Wild.Miers.) 
 
 
 
 
 
 
 
 
 
 
Fig 8.6 Morphology of Cissampelos pareira Linn. 
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POWER MICROSCOPY 
 The individual crude drug powders used in the formulation are viewed 
microscopically and the following features are noted. 
The Parenchyma with starch grains, Group of sclereids, Stone cells, Fragment of pitted 
vessels, Thick walled parenchyma cells, Thin walled fibre indicated the presence of 
Cissampelos pareira L.– Root. 
The Epidermal cells in surface view, Spongy parenchyma under epidermis, Stomata, 
Epidermis of petiole with cicatrix, Fragment of phloem tissue, Vessel fragment, Fibre bundle, 
Trichome indicated the presence of Trichosanthes dioica Roxb.– leaf. 
 The Cork in surface view, Parenchyma with starch grains, Group of stone cells, Group 
of sclereids, Sclereid, Starch grains indicated the presence of Marsdenia tenacissima (Roxb.) 
Moon. – Root. 
 The Cork in surface view, Parenchyma with mucilage, Ray parenchyma with starch 
grains, Parenchyma, Stone cells with crystals, Starch grains and prismatic crystals, Vessels 
with simple pits, Vessels with bordered pits indicated the presence of Tinospora cordifolia 
(Willd.) Meirs. - Stem. 
 The Volatile oil, Vessel fragment with bordered pits, Group of stone cells, Fibre 
bundle, Fibrosclereid, Cells with content indicated the presence of Santalum album Linn.– 
Wood. 
 The Thick-walled parenchyma, Pitted parenchyma, Cells with starch grains, 
Reticulate vessel, Pitted vessel, Spiral vessel, Parenchyma with contents indicated the 
presence of Picrorhiza kurroa Royle ex Benth. – Rhizome. 
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Characters from Patha- Cissampelos pareira L. - Root 
  
Fig 8.7 Parenchyma with starch grains Fig 8.8 Group of sclereids 
  
Fig 8.9 Stone cells Fig 8.10 Fragment of pitted vessels 
  
Fig 8.11 Thick walled parenchyma cells Fig 8.12 Thin walled fibre 
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Characters from Patola -  Trichosanthes dioica Roxb.– leaf 
  
Fig 8.13 Epidermal cells in surface view 
Fig 8.14 Spongy parenchyma under 
epidermis 
  
Fig 8.15 Stomata Fig 8.16 Epidermis of petiole with cicatrix 
  
Fig 8.17 Fragment of phloem tissue Fig 8.18 Vessel fragment 
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Fig 8.19 Fibre bundle Fig 8.20 Trichome 
Characters from Murva -  Marsdenia tenacissima (Roxb.) Moon. – Root 
  
Fig 8.21 Cork in surface view Fig 8.22 Parenchyma with starch grains 
  
Fig 8.23 Group of stone cells 
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Fig 8.24 Group of sclereids Fig 8.25 Sclereid 
  
Fig 8.26 Starch grains 
Characters from Guduci -  Tinospora cordifolia (Willd.) Meirs. - Stem 
  
Fig 8.27 Cork in surface view Fig 8.28 Parenchyma with mucilage 
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Fig 8.29 Ray parenchyma with starch 
grains 
Fig 8.30 Parenchyma 
  
Fig 8.31 Stone cells with crystals 
Fig 8.32 Starch grains and prismatic 
crystals 
  
Fig 8.33 Vessels with simple pits Fig 8.34 Vessels with bordered pits 
 
RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 101 
 
Characters from Santalum album Linn.– Wood 
  
Fig 8.35 Volatile oil 
Fig 8.36 Vessel fragment with bordered 
pits 
  
Fig 8.37 Group of stone cells Fig 8.38 Fibre bundle 
  
Fig 8.39 Fibrosclereid Fig 8.40 Cells with content 
Pitted vessels 
 
Cortical parenchyma 
Group of pitted sclereids 
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Characters from Katuki - Picrorhiza kurroa Royle ex Benth. - Rhizome 
  
Fig 8.41Thick-walled parenchyma Fig 8.42 Pitted parenchyma 
  
Fig 8.43 Cells with starch grains 
  
Fig 8.44 Reticulate vessel Fig 8.45 Pitted vessel 
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Fig 8.46 Spiral vessel Fig 8.47 Parenchyma with contents 
 
QUANTITATIVE PHYSICO-CHEMICAL ANALYSIS OF PKC 
FOREIGN ORGANIC MATTER 
 The foreign organic matter present in the raw materials was removed by mechanical 
method and the results were tabulated. It was found to be within the limits as per API. 
TABLE 8.2 DETERMINATION OF FOREIGN ORGANIC MATTER 
S.NO. Plant name 
Foreign organic 
matter % 
API Standard limit 
1 Santalum album Linn 0.5 ± 0.05 NMT 1% 
2 Trichosanthes dioica Roxb 1.0 ± 0.08 NIL 
3 Cissampelos pareira Linn. 1.24 ± 0.005 NMT-2% 
4 Picrorhiza kurroa Royle ex Benth 1.1 ± 0.05 NMT-2% 
5 Marsdenia tenacissima 1.2 ± 0.06 NMT 2% 
6 Tinospora cordifolia NIL NIL 
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ASH VALUE 
 The various ash value such as total ash, acid-insoluble ash and water soluble ash and 
water soluble ash are determined and the results were tabulated. It was found to be within the 
limits as per API. 
TABLE 8.3 DETERMINATION OF ASH VALUE 
S.No. Plant name 
Determination 
of ash value 
(Total ash) 
(% w/w) 
API 
Standard 
limit  
(% w/w) 
Acid 
insoluble 
ash 
(% w/w) 
API 
Standard 
limit 
(% w/w) 
Water 
soluble 
ash 
(% w/w) 
1 
Santalum album 
Linn 
0.7±0.03 
NMT 
1% 
0.06±0.04 
 
NMT 
1% 
NIL 
2 
Trichosanthes 
dioica Roxb 
13.36±0.02 NMT-7% 3.14±0.01 NIL NIL 
3 
Cissampelos 
pareira Linn. 
6.5±0.1 
 
NIL 
0.8±0.09 
 
NMT-1% 7.7±0.06 
4 
picrorhiza 
kurroa Royle ex 
Benth 
5.33±0.01 
 
NMT 7% 
0.30±0.006 
 
NMT-1% 1.35±0.008 
5 
Marsdenia 
tenacissima 
4.5±0.09 
 
NMT 5% 
0.1±0.02 
 
NMT 
0.5% 
0.23±0.008 
6 
Tinospora 
cordifolia 
7.5±0.09 
 
NMT 
16% 
1.16±0.009 
 
NMT-3% 12.05±0.01 
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EXTRACTIVE VALUES 
 The various extractive values such as water soluble extractive, alcohol soluble 
extractive and results were tabulated. The results obtained are found to be within the limits as 
per API. 
TABLE 8.4 DETERMINATIONS OF EXTRACTIVE VALUES 
S.No. Plant name 
Water soluble 
extractive 
(% w/w) 
API 
Standard 
limit 
 
Alcohol 
soluble 
extractive 
(% w/w) 
API 
Standard 
limit 
1 Santalum album Linn 2.5±0.09 
NLT 
1% 
10.5±0.11 NLT 8% 
2 
Trichosanthes dioica 
Roxb 
12.5±0.09 NIL 2.1±0.12 NIL 
3 
Cissampelos pareira 
Linn. 
17.5±0.12 NLT 13% 12.5±0.12 NLT 11% 
4 
picrorhiza kurroa 
Royle ex Benth 
22.5±0.06 NLT-20% 11.5±0.15 NLT 10% 
5 
Marsdenia 
tenacissima 
23±0.05 
NLT 
14% 
11±0.12 NLT 7% 
6 Tinospora cordifolia 12.05±0.01 NLT 11% 7.27±0.01 NLT 3% 
 
LOSS ON DRYING (LOG) 
 The Loss on drying results of raw materials were tabulated.  
TABLE: 8.5 DETERMINATION OF LOSS ON DRYING VALUES 
S.No. Plant name Loss On Drying (%) 
1 Santalum album Linn NIL 
2 Trichosanthes dioica Roxb 7.8% 
3 Cissampelos pareira Linn. 17.9% 
4 picrorhiza kurroa Royle ex Benth 2.87% 
5 Marsdenia tenacissima 6% 
6 Tinospora cordifolia 2.31% 
 
 
 
RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 106 
 
PH VALUE 
 The PH values of raw materials were tabulated. 
TABLE: 8.6 DETERMINATION OF PH VALUES 
S.No. Plant name PH 
1 Santalum album Linn 7.2 
2 Trichosanthes dioica Roxb 8.19 
3 Cissampelos pareira Linn. 5.80 
4 picrorhiza kurroa Royle ex Benth 6.0 
5 Marsdenia tenacissima 5.76 
6 Tinospora cordifolia 6.37 
 
STANDARDISATION OF CHURNAM 
ORGANOLEPTIC PROPERTIES 
 In-house formulation of Patoladi Kvatha Churnam was a light brown colour powder. 
It was Bitter, Aromatic and Slightly Sweetish in taste. It has a characteristic odour. 
 POWDER MICROSCOPY 
 The formulated Churnam was then viewed and the following Results were found to 
contain all the characters seen the individual powders. 
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Characters from Patha - Cissampelos pareira L.– Root 
  
Fig 8.48 Thick walled parenchyma Fig 8.49 Pitted vessel fragment 
Characters from Patola - Trichosanthes dioica Roxb.– leaf 
  
Fig 8.50 Epidermal cells in surface view Fig 8.51 Covering trichomes 
Characters from Murva - Marsdenia tenacissima (Roxb.) Moon. – Root 
  
Fig 8.52 Parenchyma with starch grains 
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Characters from Guduci - Tinospora cordifolia (Willd.) Meirs. - Stem 
   
Fig 8.53 Parenchyma with 
crystals 
Fig 8.54 Elongated starch 
grains 
Fig 8.55 Vessels with 
bordered pits 
Characters from Santalum album Linn.– Wood 
  
Fig 8.56 Volatile oil drop Fig 8.57 Fibre bundle 
Characters from Katuki - Picrorhiza kurroa Royle ex Benth. - Rhizome 
  
Fig 8.58 Reticulate vessel 
RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, MMC Page 109 
 
From the observations seen in the formulation, it is very clear that the Churnam 
posses all the ingredients in the light ratio as mentioned in the API. All the characteristic 
features matches with the powder microscopy of the individual powder samples. 
Table: 8.7 Flourescence Analysis of PKC 
S.No. Experiment Visible/Day light 
UV light 
(254nm) 
UV light (366 
nm) 
1 Drug powder as such Yellowish Brown Brown 
Fluorescent 
Yellow 
2 Powder +1N NaOH Yellow 
Greenish 
Yellow 
Yellow 
3 Powder +1 N HCl Greenish Brown 
Yellowish 
Brown 
Brown 
4 Powder +50%H2SO4 Greenish Brown Yellow Green 
5 Powder +50% HNO3 Reddish Brown Yellow 
Fluorescent 
Blue 
 
TABLE 8.8 PHYSICO- CHEMICAL ANALYSIS OF PATOLADI 
KVATHA CHURNA 
S.NO PARAMETERS RESULTS 
1 Total ash 9.8±0.09 
2 Acid insoluble ash 1.8±0.08 
3 Water soluble ash 8.2±0.09 
4 Water soluble extractive 20.5±0.12 
5 Ethanol soluble extractive 10.2±0.06 
6 Loss on drying 10.58±0.02 
7 Foreign organic matter 0.9±0.008 
8 PH 6.78±0.009 
 
All the Pysicochemical parameters were analysed. 
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TOXICOLOGICAL EVALUATION 
EVALUATION OF SAFETY PROFILE OF THE FORMULATION 
Determination of microbial contamination in PKCF. 
 The microbial load of formulation were determined and compared with WHO 
specified limits. 
Table: 8.9 Results of microbial contamination of PKCF. 
S.NO Test Observation Limit As per (API) 
1 Total Viable aerobic count (bacteria) Nil NMT 10
7
 cfu/g 
2 Total Viable aerobic count (Fungi) Nil NMT 10
4
 cfu/g 
3 Escherichia coli Nil NMT 10
2
 cfu/g 
4 Salmonella spp Nil Absence Per Gram 
 
Determination of heavy metal contamination in PKC 
 Limit test for total toxic metals such as lead, cadmium, copper, iron, nickel and zinc 
were analyzed by AAS (Atomic Absorption Spectrosocpy) and it was assured that these toxic 
heavy metals were present in the raw drug in a limited quantity which is acceptable as a non-
toxic level to be safety used to prepare a marketed formulation for human oral consumption. 
The results were tabulated as follows. 
Table 8.10 Results for heavy metal contamination of PKC 
S.NO. Heavy Metal Observation (ppm) Permissible limits (ppm) As per (API) 
1 Mercury <1 1 
2 Cadmium <0.1 0.3 
3 Lead <3 10 
4 Arsenic <2 3 
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Estimation of Aflatoxins in PKC 
 Aflatoxins are highly poisonous and carcinogenic chemicals that are produced by 
certain moulds which grow in soil. Pediatric Population is highly susceptible to Aflatoxins 
exposure. Adults have a higher tolerance to exposure, but are also at risk. The most toxic type 
of Aflatoxin is B1, which can easily permeate through the skin. The Churnam is estimated for 
the presence of Afflatoxins and the results were tabulated as follows. 
Table 8.11 Result for the estimation of Aflatoxins 
S.No. Aflatoxins Observation (ppm) Permissible Limit (ppm) As per (API) 
1 B1 0.11±0.01 0.5 
2 G1 0.11±0.01 0.5 
3 B2 0.06±0.02 0.1 
4 G2 0.06±0.01 0.1 
 
Assay of sodium by Flame Photometry: 
 High Sodium content may cause server disorders to all groups of population. Hence, 
assay of sodium content in an herbal formulation has become mandatory as per WHO 
guidelines. The result is tabulated as follows. 
Table 8.12 Result for the Assay of Sodium in PKC 
S.No. Total sodium content (mg/g) Limit (mg/g) As per (API) 
1 41.57±0.20 NLT 30 
 
PHYTOCHEMICAL STANDARDISATION 
Qualitative Phytochemical Screening 
Table 8.13 Physical nature and percentage yield of extract. 
S.No. Extract 
Method of 
Extraction 
Physical 
Nature 
Colour 
Yield 
(%w/w) 
1 Ethanol 
Ultra – 
Sonication 
Process 
Semi Solid 
Greenish 
Brown 
2.31 
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Table 8.14 Preliminary Phytochemical Screening of powdered raw 
materials of Patoladi Kvatha Churna 
S.N
O. 
Chemical 
Constituent 
T.ca 
(Stem) 
P.ka 
(Rhizome) 
S.al 
(Heart 
Wood) 
C.pa 
(Root) 
T.da 
(leaf) 
M.ta 
(Root) 
PKC 
forumulation 
1 Alkaloids + ++ + + + - + 
2 Glycosides - + + + - + + 
3 Carbohydrates + + + - - + + 
4 Steroids - - - + + + + 
5 Triterpenods - - - + - - + 
6 Flavanoids + + - - + + + 
7 Tannins - + + -  + + 
8 Phenoles + - - - ++ + + 
9 Saponins - - - + - - + 
10 
Fixed oils and 
fats 
- - - - - - - 
11 
Proteins &Free 
amino acids 
+ - + - - - + 
12 Volatile oil - + ++ - - - + 
13 
Mucilage, gums 
and resins 
- - - - - + + 
14 Terpenoids - ++ + - + - + 
15 Diterpenes + -  - - - + 
 
(+) indicates Present and (-) indicates Absent 
T.ca - Tinospora Cordifolia 
P.ka - Picrorhiza kurroa 
S.al - Santalum album 
C.pa - Cissampelos pareira 
T.da - Trichosanthes dioica 
M.ta - Marsdenia tenacissina 
Quantitative Phytochemical Screening 
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Table 8.15 DETERMINATION OF TOTAL FLAVANOID CONTENT OF 
PKC 
Concentration (µg/ml) Absorbance 
Quercetin 10 0.50 
20 0.55 
30 0.61 
40 0.81 
50 0.83 
Ethanol 0.91 
 
Fig 8.59 - Total flavonoid content 
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PHYTO –ANALYTICAL STANDARDISATION 
TLC STUDIES OF RAW MATERIAL & PKC 
Mobile phase - Toluene : Ethyl acetate (9.3:0.7) 
Stationary phase - Silica gel 60 F366 nm 
Detecting agent - UV 366 nm 
Solvent front - 10 cm 
 
Fig 8.60 TLC Identification of Six plants extract compared with PKC formulation 
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Table 8.16 TLC identification of Patoladi Kvatha Churna 
No. Name of the plant extract 
No. of 
Spot 
Rf Value 
PKC 
Formulation 
No. of 
Spot 
Rf 
Value 
1 Santalum album Linn 3 0.10, 0.4,0.86 1 0.4 
2 Trichosanthes dioica Roxb 4 0.15,0.3,0.4,0.5 1 0.5 
3 Cissampelos pareira Linn. 4 0.05,0.15,0.25, 0.86, 1 0.25 
4 
Picrorhiza kurroa Royle ex 
Benth 
4 0.12, 0.36, 0.45 , 0.86 1 0.45 
5 Marsdenia tenacissima 6 0.05,0.15,0.25,0.4,0.61,0.86 1 0.25 
6 Tinospora cordifolia 5 0.2,0.32,0.4,0.73,0.86 1 0.32 
 
GC-MS analysis of PKC 
Fig 8.61 GC-MS analysis of churnam was carried out and the result was given below. 
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Table 8.17 GC-MS PEAK REPORT OF PKC 
S.No Name RT Area 
Area 
% 
Height 
1 
BICYCLO [2.2.2] OCT-2-ENE, 
1,2,3,6- TETRAMETHYL 
17.384 72,919,376.0 21.375 43,771,096 
2 
BENZENEHEPTANOIC ACID, 
4,5-DIOXO-, 4-BROMOBUTYL 
ESTER 
18.835 21,107,116.0 6.187 48,223,408 
3 
TRICYCLO[3.3.1.1(3,7)]DECANE-
2, 6-DIONE, 4-HYDROXY- 
19.815 56,142,324.0 16.457 179,185,536 
4 OCTAN-2-ONE, 3,6-DIMETHYL 20.190 19,632,098.0 5.755 82,659,736 
5 
10-METHYL-E-11-TRIDECE-1-OL 
ACETATE 
20.871 72,508,120.0 21.254 77,168,344 
6 CYCLOHEXENE, 4,4-DIMETHYL 21.766 41,736,080.0 12.234 53,774,028 
7 
5-CYCLOOCTENE-1,2-DIOL, 
DIACETATE 
23.191 14,765,911.0 4.328 25,044,520 
8 
1-
ADAMANTANEMETHYLAMINE, 
ALPHA. –METHYL- 
24.537 6,594,532.0 1.933 24,059,220 
9 1-BENZYL-4-NITROIMIDAZOLE 24.827 4,380,001.0 1.284 18,198,248 
10 SCLAREOLOXIDE(CIS-B/C) 25.192 6,499,998.5 1.905 18,039,912 
11 
1-CYCLOHEXEN, 1-CYANO-4-
ISOPROPENYL- 
25.817 7,496,185.0 2.197 23,873,470 
12 2,3-EPOXYEXANOL 26.458 5,415,275.0 1.587 15,871,115 
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HPTLC FINGERPRINTING OF PHYTOCONSTITUENTS OF 
PATOLADI KVATHA CHURNAM FORMULATION 
Sample and standard preparation: 
Standard preparation 
100 ppm concentration of Quercetin (Marker compound) was prepared by dissolving it in 
methanol. 
Sample preparation 
 250mg of Churnam extract was accurately weighed and dissolved in 5 ml of ethanol 
by means of sonication. Each extract was filtered and volume was made up to 5ml. 
Table 8.18 Solvent system in HPTLC 
S.No. Sample Solvent System 
Saturatio
n Time 
Visualization mode/ 
Spray reagent 
1 Quercetin in PKC 
Toluene : Ethyl acetate : 
Formic acid (6:4:1) 
1 hour 
UV 254 nm, UV 366 
nm 
2 
Individual plant 
extract in PKC 
Toluene : Ethyl acetate : 
Formic acid : Methanol 
(12:9:4:0.5) 
1 hour 
UV254 nm, UV 366 
nm 
3 
Santalum album  
with Formulation 
PKC 
Toluene : Ethyl acetate  
(9.3:0.7) 
1 hour UV 366 nm 
 
Table 8.19 Identification of Quercetin in Patoladi Kvatha Churna 
 Std. Test 
Vol. applied 5 µl 10 µl 
Spot No. 1 6 
Rf value 0.46 0.46 
Area 5211.2 3662.7 
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Figure 8.62 Identification of Quercetin in Patoladi Kvatha Churna under UV254 nm 
and 366 nm 
 
Figure 8.63 Fingerprinting of Standard Quercetin 
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Figure 8.64 Finger printing of Patoladi Kvatha Churna containing Quercetin 
 
Figure 8.65 Fingerpriniting of Patoladi Kvatha Churna Containing Quercetin 
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Fig 8.66 HPTLC FOR PATOLADI KVATHA CHURNA FORMULATION EXTRACT 
COMPARED WITH INDIVIDUAL PLANT EXTRACT 
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Table 8.20 HPTLC Identification of Six Plants Extract compared with PKC 
Formulation Extract  
No. Name of the plant extract 
No. of 
Spot 
Rf Value 
PKC Formulation 
No. of 
Spot 
Rf Value 
1 Santalum album Linn 2 0.10, 0.4 2 0.10, 0.4 
2 Trichosanthes dioica Roxb 3 0.86, 0.08,0.94 3 0.86,0.08, 0.94 
3 Cissampelos pareira Linn. 4 
0.25, 0.86, 0.92, 
0.97 
4 
0.25, 0.86, 
0.92. 0.97 
4 
Picrorhiza kurroa Royle ex 
Benth 
6 
0.12, 0.36, 0.45, 
0.62, 0.69, 0.86 
3 0.45, 0.69, 0.86 
5 Marsdenia tenacissima 1 0.25 1 0.25 
6 Tinospora cordifolia 3 0.86, 0.32, 0.73 3 0.86,0.32, 0.73 
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INVITRO SKIN DISEASES SCREENING OF PKC 
INVITRO ANTI BACTERIAL AND ANTI FUNGAL PATHOGENIC 
INHIBITORY POTENTIAL OF ETHANOLIC EXTRACT OF 
PATOLADI KVATHA CHURNAM FORMULATION 
Antimicrobial assays 
 The antibacterial and anti fungal activity of the ethanol extract from the patoladi 
Kvatha Churna was studied using disc diffusion method and well diffusion method against 
Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae,Pseudomonas aeruginosa (Gram-
negative) and Fungai Candida albicans. Results suggest that the ethanolic extract has 
significant antibacterial and antifungal activity against tested bacteria and Fungai. The 
present study justifies the claimed uses of Patoladi Kvatha Churna in the traditional system of 
medicine to treat various infectious skin diseases. 
Disc Diffusion Test for Anti Bacterial Activity 
 The anti-microbial activity was assayed by disc diffusion method. The bacterial 
strains were activated by growing them in Nutrient agar at 37°C for 18 – 24 hours. Fresh 
inoculum was developed by suspending activated colonies in physiological saline solution 
(0.85% NaCl). The cell suspension was then standardized using 0.5 McFarland turbidity 
standards. The suspension was used to aseptically inoculate by swabbing the surface of 
Mueller Hinton agar plates. The impregnated discs with different concentration of extracts 
were then planted at equidistant points on top of the inoculated agar medium by sterile 
forceps. The positive control disc was also planted. The inoculated plantes were then 
incubated at 4°C for 2 hours to allow pre diffusion of extracts into the media then incubated 
at 37°C for 24 hours after which they were inspected of zones of inhibition. Anti bacterial 
activity was then evaluated by measuring the diameter of the inhibition zones. Experiment 
was carried out in triplicate and the average diameter of zone of inhibition was recorded. The 
antibacterial activity was classified as highly active (>20mm), mild active (15-20mm) and 
slightly active (12-15mm) and less then 12mm was taken as inactive. Results were expressed 
as mean ± standard deviation. The Minimum Inhibitory Concentration were also observed for 
the churnam extracts. 
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Table 8.21 Anti-bacterial activity result for the methanolic Patoladi Kvatha 
Churnam extract  
 
Values of Inhibition zones are in mm (mean ± SEM, n =3) 
STD – Standard 
 
 
Micro 
organism 
Inhibition zones diameter in mm 
STD 
Ethanolic Extract concentration 
Gram 
negative 
5000 
µg/ml 
2500 
µg/ml 
1250 
µg/ml 
625 
µg/ml 
313 
µg/ml 
25 
mg/ml 
Drug Name 
Zone of 
Inhibitio
n in mm 
Escherichia 
coil 
0 0 0 0 0 0 
Amikacin 
30µg/ml 
15±0.2 
Proteus 
vulgaris 
0 0 0 0 0 0 
Ciproflaxacin 
5 µg/ml 
Gentamycin 
10 µg/ml 
Amikacin 30 
µg/ml 
25±0.06 
 
10±0.2 
 
13±0.05 
Klebsiella 
pneumoniae 
22±0.6 15±0.1 13±0.05 11±0.09 6±0.08 28±0.05 
Gentamycin 
10 µg/ml 
18±0.06 
Pseudomonas 
aeruginosa 
20±0.06 15±0.06 10±0.2 7±0.06 5±0.06 25±0.06 
Piperacillin/Ta
zobactam 100 
µg/10 µg 
Doxycycline 
30 µg/ml 
Ciproflaxacin 
5 µg/ml 
20±0.06 
 
7±0.06 
 
20±0.06 
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Fig 8.67 Disc Diffusion Method of Anti bacterial activity of PKC Churnam Extract 
compared with Standard 
  
Zone of Inhibition of Proteus Vulgaris 
Zone of Inhibition of Pseudomonas 
aureginosa 
  
Zone of Inhibition of Escherichia coli Zone of Inhibition of Klesiella pneumonia 
 
Zone of inhibition for PKC Churnam extract compared with standard 
The Methonolic extract demonstrated antibacterial activity to four of the tested 
bacteria. Highest inhibition was demonstrated toward Klebsiella pneumonia (22 mm), and 
Pseudomonas aeruginosa (20mm), Escherichia coli, Proteus vulgaris were not sensitive to 
the extract (Table 8.21) 
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Fig 8.68 Anti bacterial activity chart of PKC extract 
 
Table 8.22 The results of MIC for antibacterial activity of ethanolic extracts of PKC at 
various doses on bacterial strains. 
Microorganism 
Name of 
extract 
Serial Dilution (µg/ml) 
5000 
µg/ml 
2500 
µg/ml 
1250 
µg/ml 
625 
µg/ml 
313 
µg/ml 
25 
mg/ml 
Escherichia 
coli 
Ethanol 
- - - - - - 
Proteus 
vulgaris 
- - - - - - 
Klebsiella 
pneumoniae 
+ + + + + + 
Pseudomonas 
aeruginosa 
+ + + + + + 
 
- No growth; + growth; 
Std. drug - Amikacinm, Ciproflaxacin, Gentamycin, Piperacillin/Tazobactam, 
Doxycyclin. 
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Well Diffusion Method for Anti Fungal Activity 
 The antifungal activity was determined by well diffusion method. 25ml of sabouraud 
(Chloramphenicol) Dextorose Agar medium (SDA) was poured into a sterile petri plates 
(Himedia, Mumbai, India). The plates were allowed to solidify, after 18 hrs (OD adjusted to 
0.6), 100 µl of above said pathogenic fungai cultures were transferred to the plate and made 
culture lawn by using sterile L-rod spreader. After five minutes setting of the pathogenic 
microbes, a sterile cork borer was used to make 5 mm well on the agar. Various 
concentrations of the samples such as 313µg/ml, 625 µg/ml, 1250 µg/ml and 2500 µg/ml, and 
5000 µg/ml were prepared and loaded into wells with various concentrations and Flucanazole 
(20 µl) and Terbinafine (20 µl) served as standard. The plates were incubated at 37°C in a 
40W florescent light source (~400 nm) for 24 h. 
 The antifungal activity was determined by measuring the diameter of the zone of 
inhibition around the well using antimicrobial zone scale (Himedia, Mumbai, India). Results 
were noted after the appropriate incubation period by measuring the diameter of zone of 
Inhibition in millimetre (mm). Experiment was carried out in triplicate and the average 
diameter of zone of inhibition was recorded. The antibacterial activity was classified as 
highly active (>20mm), mild active (15-20mm) and slightly active (12-15mm) and less then 
12mm was taken as inactive. Results were expressed as mean ± standard deviation. The 
Minimum Inhibitory Concentration were also observed for the churnam extracts. 
Table 8.23 Antifungal Activity result for the Ethanolic Patoladi Kvatha 
Churnam extract  
Microoganism 
Inhibition zones diameter in mm 
STD 
Ethanolic Extract Concentration 
 
5000 
µg/ml 
2500 
µg/ml 
1250 
µg/ml 
625 
µg/ml 
313 
µg/ml 
25 
µg/ml 
Drug Name 
Zone of 
Inhibitio
n in mm 
Candida 
albicans 
20 ± 
0.09 
0 0 0 0 0 
Flucanazole 
20 µl/ml 
Terbinafine 
20  µl/ml 
20±0.09 
 
23±0.35 
 
Values of Inhibition zones are in mm (mean ± SEM, n=3) 
STD – Standard 
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Fig 8.69 Well Diffusion Method Assay of Anti fungal activity of PKC Churnam Extract 
compared with Standard 
 
Zone of inhibition for PKC churnam extract compared with standard 
The Methonolic extract demonstrated antifungal activity to one of the tested bacteria. 
Highest inhibition was demonstrated toward Candida Albicans (20 mm) (Table 8.23). 
Fig 8.70 Anti fungal activity chart of PKC extract 
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Table 8.24 The results of MIC for anti fungal activity of ethanolic extracts of PKC at 
various doses on fungal strains. 
Microorganism 
Name of 
extract 
Serial Dilution (µg/ml) 
5000 
µg/ml 
2500 
µg/ml 
1250 
µg/ml 
625 
µg/ml 
313 
µg/ml 
25 
mg/ml 
Candida 
albicans 
Ethanol + - - - - - 
 
- No growth; + growth;  
Std. drug – Flucanazole, Terbinafine 
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9. SUMMERY AND CONCLUSION 
Raw materials standardisation was done to confirm the absence of adulterants in the 
crude drugs and thereby it ensures a quality product. 
Experiments for all physicochemical parameters were performed for both the raw 
materials as well as the finished products as per API and results obtained were verified with 
the limits and proved to be successful. 
An extensive toxicological evaluation was done using the latest equipments to ensure 
the safety profile of the formulation. 
Total bacterial count and total fungal count was almost nil. This showed that the 
formulation is free of pathogenic organisms. 
The levels of heavy metals, pesticides, Aflatoxins were also determined. The results 
obtained were appreciable. 
Estimation of sodium content in the formulation revealed that the percentage of 
sodium is within the specified limits. 
Qualitative and quantitative phytochemical screening was performed for the raw 
materials as well as the formulation. It was found to contain almost all the major 
Phytoconstituents. 
TLC studies were performed for individual crude drug. The Rf values of formulation 
are compared with the Rf value of crude drug, thereby ensuring the presence of the individual 
herb in the formulation. 
GC-MS analysis was done to identify the presence of various chemical structures with 
the help of the peaks obtained. 
HPTLC studies were also done to get the finger printing of the formulation. Quercetin 
used as bio marker. Finger printing shows the excellent presence of quercetin in the PKC. 
In vitro anti-bacterial and anti-fungal activity was performed by Disc Diffusion and 
Well Diffusion method. Since five of the raw material contains flavanoidal content which 
was revealed by preliminary phytochemical screening and HPTLC studies. The formulation 
posses an excellent anti-bacterial and anti-fungal activity. 
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Thus an Indian traditional official Ayurvedic formulation “PATOLADI KVATHA 
CHURNA” has been standardised Pharcognostically, phytochemical and even 
pharmacologically. These studies will be helpful to increase the confidence among the people 
to use this formulation for various disorders. 
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10. OUTCOME OF THE RESEARCH 
 An initiative for the development of traditional drug system was taken and the 
modern analytical methods were introduced into the ancient system of 
medicine. 
 Quality control protocol was developed for an Ayurvedic Churna. Hence this 
will serve as a key for the upcoming researchers to standardise the other 
formulation which have not been standardised yet. 
 Skin diseases property of PKC was proved and thus this could serve as a better 
alternative against the chemotherapeutically used anti bacterial and anti fungal 
agents. 
 Efforts to serve the medicinal wealth of Ayurveda will definitely raise the 
scope of Ayurveda in future. 
 More usage of herbal based medicines will improve the economical status of 
our mother nation, since India is the herbal hub. 
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11. FUTURE PERSPECTIVE 
Preformulation studies and formulation of tables from Patoladi Kvatha Churnam can 
be done to improve the patient compliance. 
Qualification of the phytoconstitutents of the Patoladi Kvatha Churnam using the  
standard biomarkers with the help of HPTLC technique can be done. 
Long term stability studies can be done to ensure shelf life of the product. 
Pharamacokinetic and pharmacodynamic studies can be performed. 
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ABSTRACT 
Plants are used as Pharmaceuticals, Nutraceuticals, Cosmetics and food 
supplements. Natural products are the integral part of human health 
care system. Patoladi Kvatha Churna is an Ayurvedic polyherbal 
formulation used for skin diseases. The aim of the study is to 
standardize the raw materials which are used to formulate the Patoladi 
Kvatha Churna. The churna containing 6 different herbal drugs is to be 
formulated and subjected to various studies like, Raw material 
standardization- To ensure the quality of raw materials, In-house 
process-To confirm that the formulation is made as per the standard 
protocols, Finsihed product standardization-To standardize the churna 
using sophisticated tools, Pharmacological studies-To perform skin disease screening of the 
churna. The raw material standardization is essential in order to review the quality of drugs 
based on the concentration of their active principles along with the physical, chemical, 
phytochemical, standardization parameters. The present work aims in standardizing the raw 
materials used for the development of churna. 
 
KEYWORDS: Raw materials, Standardization, Evaluation.  
 
INTRODUCTION  
Herbals are traditionally considered harmless and increasingly being consumed by people 
without prescription. However, pure form of herbal drugs has to be consumed. There are 
certain factors influencing phytochemical profile of medicinal plants such as seasonal 
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changes, Geographical factors, genetic variants, etc., Therefore Quality of raw drugs used in 
manufacturing and the finished Ayurvedic formulations are seen with a suspicion by the 
common people. Hence the evaluation of quality of any herbal preparation is inevitable 
requirement of industry and other Ayurveda organizations. WHO guidelines are to be strictly 
followed for the assessment of the safety, efficacy, and quality of herbal medicines is of 
prime importance. Some profit making companies are adulterating the formulations by using 
the allied species or by skipping one/other drug present in the general composition. These 
consequences will be nullified only when the rules and regulations are becoming mandatory 
for the authentication and standardization of raw materials. 
 
Composition of Patoladi Kvatha Churna.
[1,4] 
 
MATERIALS AND METHODS 
Collection and Authentication 
The plant materials were collected, cleaned and shade dried at room temperature. They were 
authenticated by the Botanist, Captain Srinivasa Murthy Regional Ayurveda Drug 
Development Institute, Arumbakkamand Siddha Central Research Institute, Arumbakkam. 
The shade dried plant materials were powdered by using electric blender. 
 
Macroscopy 
The Macroscopic characteristics of the dried rawmaterials were Observed and the results 
were obtained given in Table 1. 
 
Sl.No. 
Common 
Name 
Scientific Name 
Part 
Used  
Chemical Constituents Ethnomedicinal Uses 
1 
Kambu 
pudalai 
Trichosanthes 
dioica Roxb 
Leaf 
Saponin, essential oil, 
fixed oils 
Blood purifier, 
Diabetescancer, purgative 
2 Kadugurohini 
Picrorhiza kurroa 
Royle ex Benth 
Rhizome 
Apocyanin, picorhizin, 
Kutkin 
Asthma, cholera, fever, 
blood 
3 Sandanam 
Santalum album 
Linn                          
Heart 
Wood 
Resin, tannic acid, volatile 
oil, β-santolol, santalone 
Fever, Skin diseases 
4 Perunkurunjan 
Marsdenia 
tenacissima 
Root Resin Jaundice, fever  
5 Seenthil kodi 
Tinospora cordifolia 
(Wild.Miers.)     
Stem 
Starch, glycosides, 
Tinosporic acid, Proteins 
Leprosy, snake bite 
6 Vattathiruppi 
Cissampelos pareira 
Linn. 
Root 
Alkaloids, Berberine, 
Cissamperine, Cisseline, 
Pelosine 
Leucoderma, Leprosy 
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Powder microscopy 
A pinch of the powdered samples were mounted on a microscope slide with a drop of 
glycerinwater. Characters were observed using Nikon ECLIPSE E200 trinocular microscope 
attached with Nikon COOLPIX 5400 digital camera under bright field light. 
Photomicrographs of diagnostic characters were captured and documented and the results 
obtained were given in Table 2. 
 
Foreignorganicmatter 
The raw materials were analysed for the presence of foreign materials and the results were 
obtained and tabulated in table 3. 
 
Loss on Drying 
Loss on drying for the raw materials was done with samples as per the standard procedure. 
 
Determination of physicochemical 
Physico-chemical constants such as the ash values and extractive values for the raw 
materials were determined as per the standard procedures. 
 
Heavy Metal Determination 
Heavy metal determination is one of important analysis in order to find out the presence of 
heavy metals. It should be within the specified limits. 
 
Microbial Contamination 
Microbes such as bacteria and moulds are likely to be present in the raw material. It should be 
tested and verified whether they are in the specified limits. 
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RESULTS AND DISCUSSION 
Table 1: Macroscopic studies. 
Sl.No  Plant Name Colour Odour Taste Surface Characteristics Size and Shape    Figures 
1 
Trichosanthes 
dioica Roxb 
Upper surface 
green, lower 
surface dull 
green 
Not 
specific 
Slightly 
bitter 
Both surfaces are very 
rough with rigid hairs. 
Sinuate and dentate 
margin, cordate base, 
acute to acuminate apex. 
Ovate-oblong 
Cordate 
  
2 
Picrorhiza kurroa  
Royle ex Benth 
Greyish brown 
Pleasant 
  
Extremely 
bitter 
Rough due towrinkles, 
circular scales of roots, 
marked with numerous 
partially encircling 
closely arranged scaly 
leaves or scars of leaves, 
attached with a few roots 
fractureshort. 
Rhizome about 
5.4 cm in 
length and 6.3 
mm in width. 
  
3 
Santalum 
album Linn                         
Reddish 
brown 
Highly 
fragment 
Bitter 
Straight grains and splits 
easily longitudinally, 
heavy and solid. 
Log and chips 
varying in 
width and 
length. 
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4. Marsdena tenacissima 
Yellow to buff 
coloured with 
dark brown 
patches 
Indistinct 
Slightly 
bitter 
Longitudinally ridges and 
furrow present. Fracture, 
fibrous in wood, granular 
in bark region and short. 
Cylindrical, 
0.6 to 2.6 cm 
thick and 
varying in 
length. 
  
5. 
Tinospora cordifolia  
(Wild.Miers.)    
Dark brown Odourless Bitter 
Wood light in weight, 
bark warty, numerous 
lenticels, perforated, 
dried sample conical 
pieces, bark papery, 
longitudinal ridges, 
difficult to fracture 
Varying in 
length. 
  
6. 
Cissampelos 
pareira Linn. 
Yellowish grey Aromatic 
At first 
sweetish and 
aromatic, 
latter slightly 
bitter. 
Cylindrical tortuous 
pieces, entire or split 
longitudinally, 
longitudinally wrinkled, 
woody internally. 
1 to 4 cm in 
diameter, 10 
cm to 1.0 m 
long. 
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Table-2: Important Powder Microscopic Characters. 
Sl.No Plant Name Characteristic Feature Figures 
1. Marsdenia tenacissima 
(Root) 
Cork in surface view, 
Parenchyma with starch 
grains. 
        
2. Tinospora cordifolia(Stem) 
Vessels with bordered pits, 
Starch grains and prismatic 
crystals 
        
3. Santalum album Linn 
(Heart wood) Volatile oil, Fibre bundle 
         
4. Trichosanthes dioica Roxb 
(Leaf) Fibre bundle, Trichome 
         
5. Picrorhiza kurroa Royle 
ex Benth (Rhizome) 
Cells with starch grains, 
Spiral vessel 
        
6. Cissampelos 
pareira Linn.(Root) 
Group of sclereids, 
Fragment of pitted vessels. 
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Heavy Metal Contaminationof Patoladi Kwathachurna Table-3. 
S.No Heavy Metal Observation (ppm) 
Permissible Limits (ppm), as 
per (api) 
1, Mercury <1 1 
2. Cadmium <0.1 0.3 
3. Lead <3 10 
4. Arsenic <2 3 
 
Microbial Contamination of Patoladi Kwatha Churna Table-4. 
Sl.No Test Observation Limit as Per (Api) 
1. Total viable aerobic count(bacteria) NIL NMT 107 cfu/g 
2. Total viable aerobic count(fungi) NIL NMT 104 cfu/g 
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Physico Chemical Parametres Table-5. 
Plant name 
Foreign organic 
matter API 
Standard limit 
Determination of ash 
value (Total ash) 
API Standard limit 
Acid insolube ash 
API Standard limit 
Water soluble ash 
API Standard limit 
Water soluble 
extractive 
API Standard limit 
Alcohol soluble 
extractive API 
Standard limit 
Loss On 
Drying 
PH 
Santalum 
albumLinn 
0.5%  
NMT 1% 
0.7% 
NMT 1% 
0.06%  
NMT 1% 
NIL 
2.5% 
NLT 1% 
10.5% 
NLT 8% 
NIL 7.2 
Trichosanthes 
dioica Roxb 
1.0% 13.36% 3.14% NIL 12.5% 2.1% 7.8% 8.19 
Cissampelos 
pareira Linn. 
1.24% 
NMT-2% 
6.5% 
NMT-7% 
0.8% 
NMT-1% 
7.7% 
17.5% 
NLT 13% 
12.5% 
NLT-11% 
17.9% 5.80 
picrorhiza kurroa 
Royle ex Benth 
1.1% 
NMT-2% 
5.33% 
NMT-7% 
0.30% 
NMT-1% 
1.35% 
22.5% 
NLT-20% 
11.5% 
NLT-10% 
2.87% 6.0 
Marsdenia 
tenacissima 
1.2%  
NMT 2% 
4.5%  
NMT 5% 
0.1%  
NMT 0.5% 
0.23% 
23% 
NLT 14% 
11% 
NLT 7% 
6% 5.76 
Tinospora 
cordifolia 
NIL 
7.5% 
NMT-16% 
1.16% 
NMT-3% 
12.05% 
12.05% 
NLT-11% 
7.27% 
NLT-3% 
2.31% 6.37 
Formulation 
Of Patoladi 
Kvatha Churna 
0.9% 9.8% 1.8% 8.2% 20.5% 10.2% 10.58% 6.78 
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CONCLUSION 
All the raw materials used for the development of polyherbal ayurvedic formulation were 
standardized individually as per Ayurvedic Pharmacopoeia of India. Our findings suggested 
that all the raw materials studied were within the standard limit and they were selected for 
formulating an Ayurvedic herbal formulation for antimicrobial activity against bacterial and 
fungal pathogens that can be used in the treatment of skin diseases. 
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